Sinusitis
Sinusitis is inflammation of the paranasal sinus mucosa, typically caused by viral, bacterial, or allergic processes, resulting in obstruction of sinus drainage and accumulation of secretions.
| Exam domain | One-glance essentials |
|---|---|
| Definition / diagnosis |
|
| Epidemiology / risks |
|
| Core mechanism |
|
| Clinical picture |
|
| Investigations |
|
| Management |
|
| Complications |
|
| Prevention / follow-up |
|
| Exam traps |
|
References
[1] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (Sinusitis definition and EPOS 2020 criteria, p14–15) [2] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (Sinusitis slide, p14–15) [3] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (Sinusitis slides, p14–15) [4] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (DDx of URTI section, p120–122; Sinusitis section, p137–139) [5] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (Sinusitis section, p109–113; URTI section, p95) [6] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (NPC clinical manifestation, p251) [7] Senior notes: Maksim Medicine Notes.pdf (Bronchiectasis aetiology — syndromic associations, p301–303) [8] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (Sinusitis diagnosis, p137–139) [9] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (Acute rhinosinusitis treatment, p16; External drainage, p20; Sinusitis definition, p14) [10] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (Complicated sinusitis, p18; Acute rhinosinusitis treatment, p16) [11] Senior notes: Ryan Ho Respiratory.pdf (Rhinosinusitis management, p54) [12] Senior notes: Ryan Ho Opthalmology.pdf (Orbital cellulitis, p37–38) [13] Lecture slides: GC 215. Common nasal conditions and nasopharyngeal carcinoma.pdf (ABRS complications, p22) [14] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (Complications of ARS, p138–140) [15] Senior notes: Handbook of Internal Medicine 2024.pdf (CNS infections, p243) [16] Senior notes: Ryan Ho Neurology.pdf (Brain abscess, p150–151) [17] Senior notes: Adrian Lui Pediatrics Notes.pdf (Sinusitis management, p159) [18] Senior notes: Ryan Ho Neurology.pdf (Headache DDx, p57–58)
Sinusitis (Rhinosinusitis)
Sinusitis and rhinosinusitis refers to inflammation of the mucosa lining of the nasal cavity and paranasal sinuses [1][2]. The term "rhinosinusitis" is now preferred over "sinusitis" because inflammation of the sinuses rarely occurs without concurrent inflammation of the nasal mucosa — the nasal cavity and sinuses share a continuous respiratory epithelium, so when one is inflamed, the other almost always follows [2][3].
Breaking down the name:
- Rhino- (Greek rhis) = nose
- Sinus (Latin) = a hollow cavity or recess
- -itis (Greek) = inflammation
So "rhinosinusitis" literally means "inflammation of the nose and its associated hollow cavities."
Definition in adults (EPOS 2020, from GC/CFB lecture slides): Inflammation of the nose and the paranasal sinuses characterised by ≥2 symptoms, 1 of which should be either nasal blockage/obstruction/congestion or nasal discharge (anterior/posterior nasal drip), ± facial pain/pressure, ± reduction or loss of smell, AND either endoscopic signs of nasal polyps and/or mucopurulent discharge primarily from middle meatus and/or oedema/mucosal obstruction primarily in middle meatus, and/or CT changes: mucosal changes within the ostiomeatal complex and/or sinuses. [1]
High Yield – EPOS 2020 Definition
The EPOS 2020 definition is the standard examined in HKUMed. Note: it requires ≥2 symptoms with at least one being nasal blockage/congestion OR nasal discharge, PLUS objective evidence (endoscopic or CT). This distinguishes it from a purely symptom-based diagnosis.
2. Epidemiology
- Rhinosinusitis is one of the most common conditions seen in primary care and ENT clinics worldwide
- Acute rhinosinusitis (ARS) affects approximately 6–15% of the general population annually
- Chronic rhinosinusitis (CRS) affects approximately 5–12% of the general population in Western countries
- It is a leading reason for antibiotic prescriptions (often inappropriately, as most cases are viral)
- Highest incidence in adults = Age 45–64
- Highest incidence in children = Age 4–7
- ARS is less common in children younger than 2 years old — the sinus ostia are larger relative to the body of the sinus in younger children, making obstruction less likely
- In the very young, viral antecedent infection predisposes more to acute otitis media (AOM) than rhinosinusitis, partly because antibiotics given for AOM may prevent the evolution toward bacterial rhinosinusitis
- In Hong Kong's subtropical climate, year-round viral URTIs are common, sustaining a high incidence of acute rhinosinusitis
- Allergic rhinitis is extremely prevalent in Hong Kong (estimated 25–40% of the population), and this is a major predisposing factor for both acute and chronic rhinosinusitis
- Air pollution (particularly PM2.5 and NO₂ in urban areas) is recognized as a contributor to mucosal inflammation and CRS
- Nasopharyngeal carcinoma (NPC), which is endemic in Southern China/Hong Kong, can present with nasal symptoms and must be considered in the differential diagnosis of unilateral nasal obstruction with blood-stained discharge (see DDx section later)
- Slight female preponderance in CRS
- ARS peaks in autumn and winter (coinciding with viral URTI season), though in Hong Kong there is a secondary peak during spring/summer influenza seasons
3. Risk Factors
Understanding the risk factors requires understanding the pathophysiology — anything that causes mucosal oedema, ostial obstruction, impaired mucociliary clearance, or immunocompromise predisposes to rhinosinusitis.
Predisposing factors (from CFB lecture slides) [1]:
- Anatomical: Deviated septum, Polyp, Tumour — these physically narrow or obstruct the ostiomeatal complex (OMC), preventing sinus drainage
- Dental root infection — the roots of the upper premolars and molars are in intimate proximity to the maxillary sinus floor; periapical infection can directly seed the sinus (odontogenic sinusitis accounts for ~10–12% of maxillary sinusitis cases)
- Foreign body (especially in children)
- Nasal packing (post-surgical)
- Upper respiratory tract infection [1] — the single most common predisposing factor for ARS
- Allergic rhinitis — chronic mucosal oedema narrows ostia
- Non-allergic rhinitis (e.g., vasomotor rhinitis)
- Congenital [1]:
- Cystic fibrosis — abnormal CFTR leads to thick, dehydrated mucus with impaired mucociliary clearance; virtually all CF patients develop CRS with nasal polyps
- Primary ciliary dyskinesia (PCD) / Kartagener syndrome — dynein arm defects cause immotile cilia → impaired clearance → chronic sinusitis, bronchiectasis, situs inversus (in Kartagener's)
- Immune deficiencies (e.g., common variable immunodeficiency [CVID], selective IgA deficiency)
- Smoking (active and passive) — paralyses cilia, increases mucosal inflammation
- Immunocompromise — HIV, diabetes mellitus, chemotherapy, organ transplant recipients (especially predisposed to fungal sinusitis)
- GERD — reflux of acid can cause posterior pharyngeal and nasal mucosal inflammation
- Pregnancy — hormonal-mediated mucosal oedema
- Medications — overuse of topical nasal decongestants (rhinitis medicamentosa), cocaine use
- Swimming/diving — barotrauma to sinuses, contaminated water exposure
- Mechanical ventilation / nasogastric tubes — disrupt normal sinus drainage in ICU patients (nosocomial sinusitis)
- Air pollution, occupational dust/chemical exposure
- Dry or cold air (disrupts mucosal moisture barrier)
- Altitude changes / barotrauma (scuba diving, air travel)
4. Anatomy and Function of the Paranasal Sinuses
Understanding sinus anatomy is critical because it directly explains why sinusitis develops, where the pain localises, and how complications arise.
| Sinus | Location | Drainage | Development | Clinical Relevance |
|---|---|---|---|---|
| Maxillary | Body of maxilla, below the orbit | Middle meatus via hiatus semilunaris | Present at birth, pneumatises by age 4 | Most commonly affected. Floor is close to upper molar/premolar roots → odontogenic sinusitis. Ostium is high on medial wall → poor gravity-dependent drainage ("if your sink drain was at the top, it wouldn't drain well") |
| Ethmoid | Between orbits, within ethmoid bone | Anterior ethmoids → middle meatus; Posterior ethmoids → superior meatus | Present at birth (3–4 cells), mature by age 12 | Thin lamina papyracea separates from orbit → orbital complications. Thin cribriform plate → intracranial spread |
| Frontal | Within frontal bone, above orbit | Middle meatus via frontonasal duct | Develops ~7–8 years, fully pneumatised by late teens | Posterior wall is thin → intracranial complications (epidural abscess, meningitis). Anterior wall → Pott's puffy tumour (subperiosteal abscess with frontal bone osteomyelitis) |
| Sphenoid | Body of sphenoid bone | Sphenoethmoidal recess (superior meatus) | Develops ~3–5 years, fully pneumatised by teens | Adjacent to cavernous sinus, optic nerve, internal carotid artery, pituitary gland → rare but devastating complications |
The ostiomeatal complex is the functional unit of sinus ventilation and drainage. It is located in the lateral nasal wall at the level of the middle meatus and represents the common drainage pathway for the maxillary, anterior ethmoid, and frontal sinuses.
Key components:
- Middle turbinate
- Uncinate process
- Ethmoid infundibulum
- Hiatus semilunaris
- Ethmoid bulla
- Frontal recess
Why is the OMC so important? Because any process that causes mucosal swelling at the OMC (viral URTI, allergic rhinitis, polyps, anatomical variants) will obstruct drainage of all three anterior sinuses simultaneously. This is why sinusitis rarely involves a single sinus in isolation — it's usually a pan-sinusitis or at least multi-sinus involvement.
The normal sinus works as a self-cleaning system with three key components:
- Patent ostia — allow ventilation and drainage
- Mucociliary clearance — the pseudostratified ciliated columnar epithelium with goblet cells produces mucus that traps particles; cilia beat in a coordinated wave (~12–15 Hz) to propel mucus toward the natural ostia
- Normal mucus composition — the two-layer system (watery sol layer for ciliary beating + viscous gel layer for trapping) must be maintained
When ANY of these three components fails, the stage is set for sinusitis.
- Lighten the skull — hollow cavities reduce skull weight
- Vocal resonance — contribute to voice quality
- Humidify and warm inspired air
- Shock absorption — protect the brain from facial trauma
- Nitric oxide production — sinus epithelium produces NO, which has antimicrobial and vasodilatory functions (important for pulmonary function)
5. Etiology
Etiology (from CFB lecture slides) [1]:
- Bacterial: aerobic & anaerobic — S. pneumoniae, H. influenzae, M. catarrhalis, S. aureus, etc.
- Viral — Coronavirus, rhinovirus, etc.
- Fungal — Immunocompromised
5.2 Acute Rhinosinusitis
Most commonly rhinovirus, influenza virus, parainfluenza virus [4]. Other viruses include:
- Adenovirus
- Respiratory syncytial virus (RSV)
- Coronavirus (including SARS-CoV-2 — COVID-19 is notably associated with anosmia)
- Enterovirus
The key point: the vast majority of "sinus infections" are viral and self-limiting. This is why antibiotics are not routinely indicated.
Bacterial: S. pneumoniae, H. influenzae, Moraxella catarrhalis [1][4] are the classic triad. Additional organisms:
- S. aureus [1] — especially in nosocomial/post-surgical sinusitis
- Anaerobes (Bacteroides, Peptostreptococcus, Fusobacterium) — especially in odontogenic sinusitis
- Streptococcus pyogenes (Group A Strep)
- Gram-negative rods — more common in nosocomial/ICU sinusitis, immunocompromised
In children:
- S. pneumoniae (most common), H. influenzae (non-typeable), M. catarrhalis
- M. catarrhalis is proportionally more common in children than adults
In Hong Kong context:
- Increasing prevalence of beta-lactamase producing H. influenzae and penicillin-intermediate S. pneumoniae due to widespread antibiotic use
Fungal — Immunocompromised [1]:
- Aspergillus spp. — most common in the immunocompetent (fungal ball / allergic fungal rhinosinusitis) and in immunocompromised
- Mucor/Rhizopus (Mucormycosis / Zygomycosis) — devastating invasive disease in:
- Uncontrolled diabetes mellitus (especially DKA)
- Neutropenic patients
- Iron overload (deferoxamine use)
- Post-COVID-19 (gained prominence during the pandemic)
- Presentation: black necrotic eschar on nasal mucosa or palate, rapidly progressive orbital/cerebral invasion
- Candida — in severe immunosuppression
5.3 Chronic Rhinosinusitis
CRS is generally classified by the presence or absence of nasal polyps:
| Feature | CRSsNP (without nasal polyps) | CRSwNP (with nasal polyps) |
|---|---|---|
| Proportion | ~2/3 of CRS cases | ~1/3 of CRS cases |
| Predominant inflammation | Th1-mediated, neutrophilic | Th2-mediated, eosinophilic |
| Key cytokines | IFN-γ, TNF-α | IL-4, IL-5, IL-13 |
| Tissue oedema | Less prominent | Marked oedema → polyp formation |
| Associated conditions | Allergic rhinitis, GERD | Asthma, aspirin-exacerbated respiratory disease (AERD), allergic fungal rhinosinusitis |
- Accounts for ~10–12% of maxillary sinusitis
- Due to periapical abscess, oroantral fistula (post-extraction), dental implants
- Often polymicrobial with anaerobes
- Unilateral and foul-smelling discharge is characteristic
- Must examine the teeth and consider OPG (orthopantomogram)
- Allergic fungal rhinosinusitis (AFRS) — type I/III HSR to fungal antigens, characterised by thick "peanut butter-like" allergic mucin, often unilateral, eosinophilic, associated with atopy
- Fungal ball (mycetoma) — non-invasive accumulation of fungal hyphae in a sinus, usually maxillary; usually immunocompetent patients; treatment is surgical removal
- Invasive fungal sinusitis — as above (Mucormycosis, Aspergillosis) in immunocompromised
- Defined as ≥4 episodes of ARS per year with interim symptom resolution
- Suggests an underlying predisposing factor (anatomical, allergic, immune)
- Warrants investigation: CT sinuses, allergy testing, immune workup (immunoglobulins, HIV)
6. Pathophysiology
The fundamental pathophysiology of sinusitis can be understood as a three-step vicious cycle:
- Viral inoculation — virus deposits on nasal or conjunctival mucosa via direct contact or droplet/aerosol transmission
- Viral attachment and entry — virus attaches to receptors on epithelial cells in the nasopharynx (e.g., rhinovirus binds ICAM-1)
- Innate immune response — infected cells release pro-inflammatory cytokines (IL-1, IL-6, IL-8, TNF-α), which:
- Attract polymorphonuclear neutrophils (PMNs) → these accumulate in nasal secretions
- The colour of nasal discharge correlates with PMN content and enzymatic activity [3]:
- White: small amount of PMNs
- Yellow: increased PMNs
- Green: increased PMNs with high PMN enzymatic activity (myeloperoxidase)
- Colour of nasal discharge does NOT correlate with necessity of antibiotic use — coloured discharge is a normal, self-limited phase of an uncomplicated cold [3]
- Increased vascular permeability — release of albumin and bradykinin causes mucosal oedema, rhinorrhoea, and sore throat
- Viral rhinitis spreads to paranasal sinuses during nose blowing — nose blowing propels contaminated fluid from the nasal cavity into the sinuses (studies using contrast dye confirm this) [3]
- Sinonasal hypersecretion and oedema → the combination of mucosal oedema, copious thickened secretions, and impaired mucociliary clearance results in sinus obstruction and perpetuates the disease process [3]
- Resolution: in most cases, the immune response clears the virus within 7–10 days, mucosal swelling subsides, and normal drainage resumes
Common Misconception
Many students (and doctors) equate green/yellow nasal discharge with bacterial infection requiring antibiotics. This is FALSE. Coloured discharge simply reflects PMN activity and is a normal part of the viral cold. The criteria for bacterial rhinosinusitis are based on duration, pattern of symptoms, and severity — not discharge colour alone.
ABRS occurs most commonly as a complication of viral infection — it develops when bacteria secondarily infect an already inflamed sinus cavity [3].
The mechanism:
- Viral-induced mucosal oedema obstructs the sinus ostia
- Trapped secretions create a warm, moist, low-oxygen environment — ideal for bacterial growth
- Impaired mucociliary clearance prevents bacterial clearance
- Bacteria (from the normal nasal flora or introduced during nose blowing) proliferate
- Bacterial infection causes further inflammation, neutrophil infiltration, and purulent exudate (empyema of the sinus)
ABRS can also be associated with conditions that obstruct the nose or impair local or systemic immune function (allergic rhinitis, anatomical abnormalities, immunodeficiency) [3].
CRS is not simply a prolonged acute infection. It represents a complex, multifactorial inflammatory disorder where the relative contributions of infection, mucosal immune dysregulation, and biofilm formation are debated.
Key pathophysiological concepts in CRS:
-
Persistent mucosal inflammation — even without active infection, the inflammatory process becomes self-perpetuating due to:
- Osteitis (bone inflammation)
- Mucosal remodelling (basement membrane thickening, goblet cell hyperplasia, subepithelial fibrosis)
- Disrupted epithelial barrier function
-
Biofilm formation — bacteria form organized communities encased in a polysaccharide matrix that:
- Are resistant to antibiotics (up to 1000× more resistant than planktonic bacteria)
- Evade host immune responses
- Periodically shed planktonic bacteria, causing acute exacerbations
-
Superantigen hypothesis (in CRSwNP) — staphylococcal superantigens (from S. aureus colonizing the sinuses) activate T cells polyclonally, driving a Th2-skewed eosinophilic inflammatory response → polyp formation
-
Aspirin-Exacerbated Respiratory Disease (AERD) / Samter's Triad / NERD [5]:
- Asthma + CRSwNP + aspirin sensitivity = Samter's triad [5]
- Pathophysiology: dysregulated arachidonic acid metabolism → overproduction of cysteinyl leukotrienes and underproduction of prostaglandin E₂ → chronic eosinophilic inflammation → nasal polyps and bronchoconstriction
- Aspirin/NSAIDs inhibit COX-1, further shifting the balance toward leukotrienes → acute exacerbation
- Breaking down the acronym: NERD = NSAID-Exacerbated Respiratory Disease (newer term); previously known as AERD
-
Fungal hypothesis — some propose that fungi in the sinuses elicit an exaggerated eosinophilic response in susceptible individuals; this is the basis for allergic fungal rhinosinusitis (AFRS)
7. Classification
| Category | Duration | Key Features |
|---|---|---|
| Acute rhinosinusitis (ARS) | < 12 weeks (some sources say < 4 weeks) | Most common; usually viral |
| Subacute rhinosinusitis | 4–12 weeks | Transition zone between acute and chronic |
| Chronic rhinosinusitis (CRS) | ≥12 weeks | Requires objective confirmation (endoscopy or CT) |
| Recurrent acute rhinosinusitis | ≥4 episodes per year with interim symptom resolution | Investigate for underlying cause |
EPOS 2020 Duration Classification
Note that EPOS 2020 simplifies the classification to Acute: < 12 weeks and Chronic: ≥12 weeks [1], without a formal "subacute" category. However, some guidelines (e.g., AAO-HNS) still use < 4 weeks for acute, 4–12 weeks for subacute, and > 12 weeks for chronic. For HKUMed exams, the CFB lecture slide uses Acute: < 12 weeks; Chronic: ≥12 weeks [1], so follow this classification.
| Category | Description |
|---|---|
| Acute viral rhinosinusitis | ARS with viral etiology; symptoms < 10 days and not worsening |
| Uncomplicated acute bacterial rhinosinusitis | ARS with bacterial etiology without clinical evidence of extension outside paranasal sinus and nasal cavity |
| Complicated acute bacterial rhinosinusitis | ARS with bacterial etiology WITH clinical evidence of extension outside paranasal sinus and nasal cavity (orbital, intracranial, etc.) |
| Type | Features |
|---|---|
| CRSsNP (without nasal polyps) | ~2/3 of CRS; predominantly neutrophilic/Th1; associated with anatomical factors, biofilms |
| CRSwNP (with nasal polyps) | ~1/3 of CRS; predominantly eosinophilic/Th2; associated with asthma, AERD, AFRS |
| AFRS (Allergic Fungal Rhinosinusitis) | Type I + III HSR to fungi; eosinophilic mucin with fungal hyphae; atopic patient; typically unilateral |
| Fungal ball (Mycetoma) | Non-invasive; dense fungal concretion in a single sinus; immunocompetent |
| Invasive fungal sinusitis | Acute (fulminant) or chronic (indolent); immunocompromised; tissue invasion by fungi |
8. Clinical Features
The clinical features of rhinosinusitis are best understood by linking each symptom/sign back to its pathophysiological basis.
8.1 Symptoms
| Symptom | Pathophysiological Basis |
|---|---|
| Nasal congestion/blockage/obstruction [1][3] | Mucosal oedema (vascular engorgement + inflammatory exudate) narrows the nasal passage and obstructs airflow. In CRSwNP, polyps physically occlude the nasal cavity. |
| Nasal discharge (anterior or posterior nasal drip) [1][3] | Hypersecretion from goblet cells and submucosal glands in response to inflammation; transudate from increased vascular permeability. Purulent nasal discharge suggests high PMN content. Posterior nasal drip irritates the pharynx → cough, throat clearing. |
| Facial pain/pressure [3] | Accumulated secretions and negative pressure within an obstructed sinus stimulate trigeminal (CN V) nociceptors in the sinus mucosa and periosteum. Pain worsens or localises to sinuses when bending forward because this increases hydrostatic pressure in the obstructed sinus [3]. Location of pain maps to the affected sinus: maxillary → cheek/upper teeth; frontal → forehead; ethmoid → between/behind eyes; sphenoid → vertex/occipital. |
| Hyposmia or anosmia [3] | Mucosal oedema and discharge physically obstruct odorant molecules from reaching the olfactory epithelium in the roof of the nasal cavity. In CRS, chronic inflammation may cause neural damage to olfactory neurons. |
| Symptom | Pathophysiological Basis |
|---|---|
| Dental/tooth pain [3] | Maxillary tooth pain occurs because the floor of the maxillary sinus is in intimate proximity to the roots of upper premolars and molars (2nd premolar, 1st and 2nd molars). Inflamed maxillary sinus mucosa or pressure from accumulated secretions irritates the superior alveolar nerves (branches of CN V₂). This also works in reverse — dental infection can cause maxillary sinusitis. |
| Headache [3] | Referred pain from trigeminal nociceptors; may mimic primary headache disorders (migraine, tension-type). Sphenoid sinusitis classically causes vertex or occipital headache. |
| Fever [3] | Typically absent in acute viral rhinosinusitis or only present early in illness [3]. Presence of high fever (>38°C) with purulent discharge for ≥3–4 days suggests bacterial etiology. |
| Cough | Post-nasal drip irritates the pharynx and larynx → cough reflex. Worse at night (lying down increases posterior drainage). Very common cause of chronic cough in children. |
| Fatigue / Malaise | Systemic inflammatory response; cytokine-mediated (IL-1, IL-6, TNF-α cause the "sickness behaviour" — fatigue, anorexia, myalgia). |
| Halitosis (bad breath) | Stagnant, infected secretions in the sinuses and posterior pharynx harbour anaerobic bacteria that produce volatile sulfur compounds. Especially prominent in odontogenic sinusitis. |
| Ear symptoms: ear pain, pressure/fullness, hearing loss, tinnitus [3] | Eustachian tube dysfunction — the Eustachian tube opens into the nasopharynx; mucosal oedema and secretions can obstruct the tube, leading to negative middle ear pressure, serous effusion, and conductive hearing loss. Maxillary sinus infection may cause otalgia referred through sensory pathways of CN V (auriculotemporal nerve, a branch of V₃) [3]. |
| Feature | Acute Viral RS | Acute Bacterial RS |
|---|---|---|
| Duration | < 10 days, improving | ≥10 days without improvement, OR onset of severe symptoms for ≥3–4 days, OR "double sickening" |
| "Double sickening" | Absent | Classic pattern: initial improvement followed by worsening after 5–6 days — this bimodal course strongly suggests secondary bacterial infection |
| Discharge | Clear → may become coloured (normal) | Discoloured, purulent nasal discharge (but colour alone is not diagnostic) |
| Pain | Mild, diffuse | Severe, localised, often unilateral |
| Fever | Absent or early and brief | Fever >38°C |
| Inflammatory markers | Normal | ↑ESR/CRP |
Criteria for bacterial rhinosinusitis (from senior notes and EPOS/AFP): ≥3 of — (1) Double sickening, (2) Discoloured purulent nasal discharge, (3) Severe localised pain, (4) Fever >38°C or ↑ESR/CRP [4][5]
Double Sickening – What Is It?
"Double sickening" means the patient initially has a typical viral URTI that starts improving, but then around day 5–7, the symptoms worsen again (new fever, worsening discharge, increasing facial pain). This bimodal course is the hallmark of secondary bacterial superinfection of the sinuses.
8.2 Signs
| Sign | Pathophysiological Basis |
|---|---|
| Erythema/oedema with tenderness over sinus areas [4][5] | Inflammation of the sinus mucosa and periosteum → referred tenderness over the affected sinus. Palpation: press over frontal sinus (supraorbital area), maxillary sinus (cheek), ethmoidal sinus (bridge of nose/medial orbit). These signs are not diagnostic in isolation [4]. |
| Opacification of maxillary/frontal sinus upon transillumination [4][5] | A penlight placed against the palate (maxillary) or supraorbital rim (frontal) in a dark room. Fluid/pus-filled sinus does not transmit light → opaque. Low sensitivity and specificity; largely of historical interest. |
| Periorbital oedema / erythema | Suggests anterior ethmoid sinusitis with possible preseptal or orbital cellulitis — a complication requiring urgent assessment. |
| "Pott's puffy tumour" | A doughy, non-tender frontal swelling = subperiosteal abscess + frontal bone osteomyelitis. Seen in complications of frontal sinusitis. |
Anterior rhinoscopy findings:
- Mucosal inflammation: oedema, narrowing of meatus, inferior turbinate hypertrophy — result of inflammatory vasodilation and extravasation
- Discharge: copious watery or purulent discharge — watery = viral/allergic; purulent = bacterial/late viral
- Co-existent anatomical risk factors: polyps, septal deviation — these predispose to sinusitis and may be found incidentally
More informative than anterior rhinoscopy, allows visualization of the middle meatus and OMC:
- Mucopurulent discharge from the middle meatus (draining from maxillary/anterior ethmoid/frontal sinuses) or sphenoethmoidal recess (draining from posterior ethmoid/sphenoid sinuses)
- Polyps — grey-white, oedematous protrusions that are mobile and insensitive to pain (cf. swollen turbinate, which is vascular, pink, and sensitive) [5]
- Mucosal oedema, crusting, scarring (in CRS)
- Masses (must exclude NPC in Hong Kong — especially in the setting of unilateral nasal obstruction with blood-stained discharge)
| Feature | Nasal Polyp | Swollen Turbinate |
|---|---|---|
| Colour | Grey-white, translucent | Pink-red (vascular) |
| Mobility | Mobile — moves with probe | Fixed to lateral wall |
| Pain on probing | Insensitive to pain | Sensitive/painful |
| Surface | Smooth, oedematous | Has visible vessels |
| Response to decongestant | Does NOT shrink | Shrinks with topical decongestant |
Cardinal S/S of CRS: mucopurulent nasal drainage + blocked nose + facial discomfort + ↓/loss of smell [5]
The following features suggest complications or an alternative serious diagnosis and require urgent investigation:
| Red Flag | Concern |
|---|---|
| Periorbital oedema/erythema, proptosis, ophthalmoplegia, ↓visual acuity | Orbital complications (preseptal/orbital cellulitis, subperiosteal abscess) |
| Severe headache, altered mental state, seizures, focal neurological deficits | Intracranial complications (meningitis, intracranial abscess, cavernous sinus thrombosis) |
| High fever, toxic appearance, rapidly progressive | Invasive fungal sinusitis (in immunocompromised); complicated bacterial sinusitis |
| Black necrotic eschar on nasal mucosa or palate | Mucormycosis — urgent surgical debridement required |
| Unilateral symptoms, especially blood-stained discharge, cranial nerve palsies | Nasopharyngeal carcinoma (endemic in HK), sinonasal malignancy |
| Frontal swelling ("Pott's puffy tumour") | Frontal bone osteomyelitis with subperiosteal abscess |
Understanding referred pain patterns helps localize the affected sinus:
| Sinus | Location of Pain |
|---|---|
| Maxillary | Cheek, upper teeth, below the eye |
| Frontal | Forehead, above the eye |
| Anterior Ethmoid | Between the eyes, bridge of nose, medial orbit |
| Posterior Ethmoid | Behind the eyes, temporal area |
| Sphenoid | Vertex of skull, occipital area, deep retro-orbital |
The pain is referred along branches of CN V:
- Maxillary sinus → CN V₂ (maxillary division)
- Frontal sinus → CN V₁ (ophthalmic division, supraorbital nerve)
- Ethmoid sinuses → CN V₁ (nasociliary nerve)
- Sphenoid sinus → CN V₁ and V₂
9. Special Populations
- Sinuses develop at different rates (maxillary and ethmoid present at birth; frontal and sphenoid develop later) → frontal sinusitis is rare before age 7–8
- Children have an average of 6–8 viral URTIs per year → more opportunities for ARS
- Clinical presentation may be less specific: chronic cough (especially nocturnal/post-nasal drip), irritability, halitosis, periorbital oedema
- Adenoid hypertrophy can obstruct the posterior nasal cavity and OMC, predisposing to sinusitis
- Cystic fibrosis and primary ciliary dyskinesia should be considered in children with recurrent/chronic sinusitis with or without nasal polyps
- Higher risk of invasive fungal sinusitis (Mucormycosis, Aspergillus)
- Atypical organisms more common (Pseudomonas, Gram-negatives, Nocardia)
- Clinical presentation may be muted (lack of fever, poor inflammatory response)
- Low threshold for imaging (CT sinuses) and tissue biopsy
- Aggressive surgical management often needed
- Mucociliary clearance declines with age → increased susceptibility
- Mucosal atrophy → dryness, crusting
- Often on multiple medications (e.g., anticholinergics that dry secretions)
- May present atypically (confusion, anorexia rather than classic symptoms)
High Yield Summary
Definition: Rhinosinusitis = inflammation of the nasal cavity and paranasal sinuses. EPOS 2020 requires ≥2 symptoms (one must be nasal blockage/discharge) + objective evidence.
Classification: Acute ( < 12 wk), Chronic (≥12 wk), Recurrent acute (≥4 episodes/yr with resolution).
Etiology: Viral (>90% — rhinovirus MC), Bacterial (0.5–2% — S. pneumoniae, H. influenzae, M. catarrhalis), Fungal (immunocompromised).
Pathophysiology: Precipitating event → mucosal oedema → ostial obstruction → mucus stasis → ↓O₂ → bacterial overgrowth → more inflammation (vicious cycle). Nose blowing propels contaminated fluid into sinuses.
Key clinical criteria for bacterial RS: ≥3 of: (1) Double sickening, (2) Purulent discharge, (3) Severe localized pain, (4) Fever >38°C or ↑ESR/CRP.
Nasal discharge colour ≠ bacterial infection: Coloured discharge reflects PMN activity and is normal in viral colds.
Nasal polyps: Grey-white, mobile, painless (vs turbinate: pink, fixed, tender). Think CRSwNP, Samter's triad (asthma + polyps + aspirin sensitivity), cystic fibrosis, AFRS.
OMC: The bottleneck — any swelling here obstructs maxillary + anterior ethmoid + frontal sinuses simultaneously.
Red flags: Periorbital signs (orbital complication), altered consciousness/FND (intracranial complication), black eschar (mucormycosis), unilateral blood-stained discharge (NPC in HK).
Active Recall - Sinusitis (Overview, Etiology, Pathophysiology, Clinical Features)
[1] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (Sinusitis slide, p14–15) [2] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (Sinusitis section, p133–135) [3] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (Sinusitis section, p109–113; URTI section, p95) [4] Senior notes: Ryan Ho Respiratory.pdf (Rhinosinusitis section, p54) [5] Senior notes: Adrian Lui Pediatrics Notes.pdf (Sinusitis section, p159)
Differential Diagnosis of Sinusitis (Rhinosinusitis)
The differential diagnosis of rhinosinusitis is essentially the differential of a patient presenting with nasal congestion, nasal discharge, facial pain/pressure, and/or hyposmia. The key clinical challenge is threefold:
- Is this rhinosinusitis at all, or is it something else mimicking it? (e.g., allergic rhinitis, migraine, dental pathology, malignancy)
- If it is rhinosinusitis, is it viral or bacterial? (determines need for antibiotics)
- Are there complications or red flags suggesting extension beyond the sinuses? (orbital, intracranial)
The approach is best structured by the dominant presenting symptom, because patients don't walk in saying "I have rhinosinusitis" — they present with nasal symptoms, facial pain, headache, or a combination.
2. Differential Diagnosis: Conditions Mimicking Rhinosinusitis
| Condition | Key Distinguishing Features | Why it mimics sinusitis |
|---|---|---|
| Common cold (Viral URTI) | Symptoms < 10 days and not worsening [2][3]. Self-limiting. Low-grade fever early only. | Shares nasal congestion, rhinorrhoea, and mild facial pressure. The critical distinction: common cold resolves spontaneously, whereas bacterial sinusitis persists ≥10 d, has double sickening, or presents with severe symptoms [2][3]. |
| Allergic rhinitis [2] | Allergic, seasonal or vasomotor rhinitis [2]. Sneezing, clear watery rhinorrhoea, nasal itching, conjunctival itching/tearing. Pale/boggy turbinates on rhinoscopy. Seasonal or perennial pattern. Personal/family atopy history. | Shares nasal congestion and discharge with sinusitis. However, allergic rhinitis features prominent itching (nose, eyes, palate) and sneezing — these are NOT features of sinusitis. Allergic rhinitis is also a major risk factor for sinusitis (mucosal oedema → ostial obstruction), so the two frequently co-exist. |
| Vasomotor (non-allergic) rhinitis | Nasal congestion and clear rhinorrhoea triggered by temperature changes, strong odours, alcohol, spicy food, emotions. No itching/sneezing. Negative allergy testing. | Shares nasal obstruction and discharge, but no facial pain, no purulence, and triggers are non-infectious. Pathophysiology: autonomic dysfunction → parasympathetic overactivity → glandular hypersecretion and vascular engorgement. |
| Rhinitis medicamentosa | Rebound nasal congestion after prolonged use ( > 5–7 days) of topical nasal decongestants (e.g., oxymetazoline, xylometazoline). History of chronic decongestant use is diagnostic. | Presents with severe nasal obstruction that worsens despite (and because of) decongestant use. Mechanism: tachyphylaxis to α-adrenergic receptor stimulation → rebound vasodilation and mucosal oedema. |
| Nasal foreign body (especially children) | Unilateral, foul-smelling, purulent or blood-stained nasal discharge. History of insertion (may be denied). Visible on anterior rhinoscopy or endoscopy. | Unilateral purulent discharge mimics sinusitis. Key clue: unilateral in a child = foreign body until proven otherwise. |
| Nasal polyps (CRSwNP) | Grey-white, oedematous protrusions; mobile and insensitive to pain [5]. Progressive nasal obstruction, hyposmia/anosmia. Bilateral in most cases. | Polyps cause nasal obstruction and may predispose to secondary sinusitis. Important to distinguish from antrochoanal polyp (unilateral, usually from maxillary sinus, more common in children — may mimic unilateral mass). |
| Adenoid hypertrophy (children) | Chronic mouth breathing, snoring, nasal voice, recurrent otitis media. Lateral neck X-ray or nasopharyngoscopy shows enlarged adenoids. | Causes chronic nasal obstruction and post-nasal drip in children, mimicking CRS. |
HK High Yield – Unilateral Nasal Symptoms
In Hong Kong, any patient with persistent unilateral nasal obstruction, especially with blood-stained discharge or associated cranial nerve palsies, must be investigated for nasopharyngeal carcinoma (NPC) until proven otherwise. NPC is endemic in Southern Chinese populations. A high index of suspicion is essential — do not dismiss as "just sinusitis."
NPC deserves special attention because of its endemic prevalence in Hong Kong and its ability to masquerade as chronic rhinosinusitis.
| Feature | Rhinosinusitis | NPC |
|---|---|---|
| Nasal obstruction | Usually bilateral | Often unilateral initially |
| Discharge | Bilateral, mucopurulent | Blood in postnasal drip is significant in early diagnosis [7]; frank epistaxis is rare ("blood usually goes down the nasopharynx directly" [7]) |
| Hearing loss | Conductive (Eustachian tube dysfunction, bilateral) | Unilateral tinnitus with hearing loss [7]; unilateral serous otitis media (Eustachian tube blocked by tumour) |
| Cranial nerve involvement | Absent | Diplopia (CN III, IV, VI), trismus, facial pain and numbness (CN V) [7] — due to skull base erosion or para-cavernous sinus invasion |
| Neck mass | Absent | Lymphadenopathy (upper neck mass) — MOST common initial presenting symptom [7]; typically Level II and retropharyngeal, often bilateral |
| EBV markers | Normal | ↑EBV VCA-IgA, EBV EA-IgA; ↑plasma EBV DNA [7] |
- Inverted papilloma — benign but locally aggressive; unilateral nasal obstruction, epistaxis; endoscopic appearance is papillomatous/cerebriform; risk of malignant transformation (~5–15%)
- Squamous cell carcinoma of the sinuses — rare; unilateral obstruction, pain, bloody discharge, facial swelling, infraorbital nerve (CN V₂) numbness
- Esthesioneuroblastoma (olfactory neuroblastoma) — arises from olfactory epithelium; unilateral obstruction, epistaxis, anosmia
- Lymphoma — nasal NK/T-cell lymphoma is more common in Asian populations; destructive midline lesion, nasal obstruction, epistaxis, facial swelling
Many patients with "sinus headache" actually have a primary headache disorder. Studies show that up to 80–90% of self-diagnosed or physician-diagnosed "sinus headache" is actually migraine [6].
| Condition | Key Distinguishing Features | Why it mimics sinusitis |
|---|---|---|
| Migraine | Unilateral pulsating headache, 4–72h, nausea/vomiting, photophobia, phonophobia, preceded by aura (in ~1/3). Debilitating; increased by movement [6]. | Migraine commonly involves the trigeminal distribution (forehead, periorbital, cheek) and can cause nasal congestion and rhinorrhoea via trigeminovascular activation → parasympathetic nasal congestion. This is why patients report "sinus pressure" and mistakenly believe they have sinusitis. Key difference: migraine has nausea, photophobia, and phonophobia, which are NOT features of sinusitis. |
| Tension-type headache (TTH) | Bilateral band-like tightness, 30 min–7 d [6]. Mild-moderate severity. No nausea, no photophobia. | The bilateral pressure can be misinterpreted as "sinus pressure." Absence of nasal symptoms helps differentiate. |
| Cluster headache | Severe unilateral periorbital deep, piercing pain, 15 min–3 h, rapid onset [6]. Ipsilateral autonomic features (lacrimation, nasal congestion, conjunctival injection, Horner's syndrome) [6]. Restlessness. Alcohol and GTN are triggers [6]. Periodicity and clustering. | The ipsilateral nasal congestion and lacrimation can be mistaken for unilateral sinusitis. Key difference: cluster headache is excruciating but brief (15 min–3 h), occurs in clusters, and has prominent autonomic features. The patient is restless (pacing, head-banging) — unlike a sinusitis patient who sits quietly. |
| Trigeminal neuralgia | Unilateral lancinating pain in CN V₂ or V₃ distribution, triggered by touch, chewing, talking. Electric shock-like, lasts seconds. | Pain may be in the maxillary/cheek region, mimicking maxillary sinusitis. Key difference: the pain is lancinating/electric, very brief (seconds), and has trigger zones. No nasal symptoms. |
| Giant cell (temporal) arteritis | Age > 50, new-onset headache, temporal tenderness, jaw claudication, visual symptoms (amaurosis fugax, visual loss), polymyalgia rheumatica. ↑ESR/CRP. | Temporal/frontal headache can mimic frontal sinusitis. Key difference: systemic inflammation, scalp tenderness, jaw claudication, and risk of irreversible visual loss. Urgent diagnosis (temporal artery biopsy, high-dose steroids). |
Facial pain in DDx of headache: trigeminal neuralgia, herpes zoster, post-herpetic neuralgia, dental/TMJ diseases, sinusitis [6]
| Condition | Key Distinguishing Features | Why it mimics sinusitis |
|---|---|---|
| Periapical abscess / dental caries | Toothache localised to a specific tooth, worse with percussion, hot/cold sensitivity. Periapical lucency on OPG. | Upper premolar/molar dental pain can mimic (or cause) maxillary sinusitis. The relationship is bidirectional: dental infection can cause sinusitis (odontogenic), and maxillary sinusitis can cause referred dental pain. |
| TMJ dysfunction | Preauricular pain, worse with chewing/jaw movements, clicking/crepitus of TMJ, limited mouth opening. | Facial pain in the cheek/preauricular area can mimic maxillary or sphenoid sinusitis. No nasal symptoms. |
| Condition | Key Distinguishing Features |
|---|---|
| Granulomatosis with polyangiitis (GPA, formerly Wegener's) | Triad of sinusitis, pulmonary infiltrates, and nephritis [8]. Destructive sinusitis (saddle-nose deformity), bloody nasal crusting, subglottic stenosis. c-ANCA/PR3 positive. |
| Eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss) | Asthma, eosinophilia, CRS with polyps, pulmonary infiltrates, vasculitis. p-ANCA/MPO may be positive. |
| Sarcoidosis | Non-caseating granulomas; nasal mucosal nodules, crusting, obstruction. Systemic features (bilateral hilar lymphadenopathy, erythema nodosum, uveitis). |
| SLE | Can cause nasal mucosal ulceration, crusting, and secondary sinusitis. Look for malar rash, arthritis, serositis, renal involvement. |
| Relapsing polychondritis | Nasal chondritis → saddle-nose. Auricular chondritis (sparing lobes). Respiratory tract involvement. |
High Yield – GPA (Wegener's)
Any patient with chronic, destructive sinusitis (especially with bloody crusting, saddle-nose deformity) + pulmonary involvement (haemoptysis, nodules) + renal involvement (haematuria, proteinuria) should be investigated for GPA. Check c-ANCA/PR3 antibodies. This is a vasculitis emergency that requires prompt immunosuppressive therapy [8].
These are not "differential diagnoses" per se, but rather extensions/complications of sinusitis that change the clinical picture dramatically and must be recognized urgently.
| Complication | Clinical Clues | Pathophysiology |
|---|---|---|
| Preseptal cellulitis | Eyelid swelling and erythema, no proptosis, no ophthalmoplegia, no visual impairment [9]. | Infection anterior to the orbital septum — a tissue barrier that usually prevents deeper spread. Does NOT involve orbital contents. Typically from ethmoid sinusitis or skin infection. Managed with oral antibiotics. |
| Orbital cellulitis [9] | Eyelid swelling, deep eye pain, pain with eye movement, proptosis, ophthalmoplegia ± diplopia, visual impairment ± RAPD, chemosis, fever [9]. Ophthalmic emergency [9]. | Infection posterior to the orbital septum, involving orbital fat and extraocular muscles. Most commonly from rhinosinusitis (ethmoid sinus via lamina papyracea) [9]. The lamina papyracea is paper-thin and perforated by neurovasculature, providing a direct conduit for infection. |
| Subperiosteal abscess | Proptosis with globe displacement (usually laterally and inferiorly from a medial abscess). CT shows rim-enhancing collection along medial orbital wall. | Pus collects between the periorbita and lamina papyracea. Often requires surgical drainage. |
| Intracranial abscess (brain abscess, subdural empyema) [4][10] | Headache (most common symptom), fever, seizures, focal neurological deficits [10]. Altered mental status. | Direct spread from frontal/ethmoid/sphenoid sinuses through bone, or retrograde thrombophlebitis via diploic veins. Subdural empyema: collection of pus between dura and arachnoid — spread from sinusitis/AOM/mastoiditis [10]. |
| Meningitis | Headache, fever, neck rigidity (Kernig's/Brudzinski's signs), photophobia. | Direct spread from sphenoid or posterior ethmoid sinuses to meninges, or haematogenous spread. S. pneumoniae is MC bacterial cause; risk factors include sinusitis [10]. |
| Septic cavernous sinus thrombosis (CVST) | Bilateral orbital signs (because the two cavernous sinuses communicate), CN III/IV/V₁/V₂/VI palsies, proptosis, chemosis, high fever, rapid deterioration. | Infection spreads from sphenoid or ethmoid sinuses to the cavernous sinus via valveless emissary veins. Thrombosis forms within the cavernous sinus, entrapping the traversing cranial nerves. Potential spread to intracranial structures via superior and inferior orbital veins (superior orbital vein without valves) [9]. |
| Pott's puffy tumour [4] | Doughy, fluctuant frontal swelling. | Facial cellulitis + osteomyelitis of sinus bones [4]. Subperiosteal abscess of the frontal bone from frontal sinusitis eroding through the anterior table. |
| Invasive fungal sinusitis | Black necrotic eschar on nasal mucosa/palate, rapid progression, immunocompromised host (DKA, neutropenia). | Angioinvasive fungi (Mucor/Rhizopus, Aspergillus) invade blood vessel walls → thrombosis → tissue necrosis. Requires emergent surgical debridement + systemic antifungals (amphotericin B). |
3. DDx by Presenting Symptom — Quick Reference
| Category | Conditions |
|---|---|
| Inflammatory | Allergic rhinitis, vasomotor rhinitis, rhinitis medicamentosa, rhinosinusitis (acute/chronic), nasal polyps |
| Structural | Deviated nasal septum, turbinate hypertrophy, concha bullosa, choanal atresia (neonates), adenoid hypertrophy (children) |
| Neoplastic | NPC (HK!), inverted papilloma, SCC, NK/T-cell lymphoma, esthesioneuroblastoma, juvenile nasopharyngeal angiofibroma (adolescent males) |
| Foreign body | Especially in children — unilateral foul-smelling discharge |
| Granulomatous | GPA, sarcoidosis, TB, rhinoscleroma |
| Systemic | Hypothyroidism (mucosal oedema), pregnancy (hormonal rhinitis), acromegaly |
| Category | Conditions |
|---|---|
| Sinogenic | ARS (viral/bacterial), CRS, complicated sinusitis |
| Dental | Periapical abscess, impacted tooth, TMJ dysfunction |
| Neurological | Migraine (most common misdiagnosis!), cluster headache, trigeminal neuralgia, post-herpetic neuralgia |
| Vascular | Giant cell arteritis |
| Neoplastic | NPC with CN V involvement, sinonasal malignancy |
| Referred | Otitis media, cervical spine pathology |
| Bilateral | Unilateral |
|---|---|
| Viral URTI (normal self-limiting coloured phase) | Foreign body (children) |
| ABRS | Odontogenic sinusitis |
| CRS | Unilateral fungal ball |
| Allergic/non-allergic rhinitis with secondary infection | NPC or sinonasal malignancy |
| Choanal atresia (unilateral, neonates) | |
| CSF rhinorrhoea (clear, watery — test for β₂-transferrin) |
4. Key Distinctions for Exam Purposes
This is arguably the most important clinical distinction because it determines whether antibiotics are indicated [2][3][4].
| Feature | Viral URTI / Acute Viral RS | Acute Bacterial RS |
|---|---|---|
| Duration | < 10 days, not worsening [2][3] | ≥10 days without improvement, OR severe onset ≥3–4 days, OR double sickening after 5–6 days [2][3] |
| Fever | Absent or early/brief | High fever (>38°C) |
| Discharge colour | May be coloured (normal) | Purulent (but not diagnostic alone) |
| Pain | Mild, bilateral | Severe, localised, often unilateral |
| Clinical course | Gradual improvement | Persistent or biphasic (double sickening) |
Differentiated from common cold by persistence, increased severity or worsening of symptoms [2]
| Feature | Allergic Rhinitis | Rhinosinusitis |
|---|---|---|
| Itching (nose, eyes, palate) | Prominent | Absent |
| Sneezing (paroxysmal) | Prominent | Absent or minimal |
| Discharge | Clear, watery | May be purulent |
| Facial pain | Absent | Present (if sinusitis) |
| Turbinates | Pale, boggy | Erythematous, swollen |
| Conjunctival injection | Common | Absent |
| Eosinophilia | May be present | Absent (in bacterial) |
| Allergen triggers | Identifiable | Viral URTI triggers |
This distinction is critical because orbital cellulitis is an ophthalmic emergency requiring IV antibiotics and often surgical drainage, while preseptal cellulitis is managed with oral antibiotics.
| Feature | Preseptal Cellulitis | Orbital Cellulitis |
|---|---|---|
| Eyelid swelling | Yes | Yes |
| Pain with eye movement | No | Yes |
| Proptosis | No | Yes (may be subtle) |
| Ophthalmoplegia ± diplopia | No | Yes (most important feature) |
| Visual impairment ± RAPD | No | May be present |
| Chemosis | Rarely | May be present |
| Management | Oral Abx | High dose IV Abx |
Orbital cellulitis is an ophthalmic emergency. It does NOT involve the globe itself. More common in young children. Most common cause is rhinosinusitis from ethmoid sinus via lamina papyracea. [9]
When a patient presents with chronic sinusitis as part of a multi-system pattern, consider these syndromic associations:
| Syndrome | Pattern | Underlying Condition |
|---|---|---|
| Sinusitis + bronchiectasis + situs inversus | Kartagener syndrome (primary ciliary dyskinesia + situs inversus) [11] | |
| Sinusitis + nasal polyps + recurrent pneumonia + steatorrhoea | Cystic fibrosis [11] | |
| Sinusitis + bronchiectasis + male infertility | Young syndrome or PCD [11] | |
| Sinusitis + yellow nails + lymphoedema + pleural effusion | Yellow nail syndrome [11] | |
| CRSwNP + asthma + aspirin sensitivity | Samter's triad (AERD/NERD) [5] | |
| Sinusitis + pulmonary infiltrates + nephritis | GPA (Wegener's) [8] | |
| Sinusitis + asthma + eosinophilia + vasculitis | EGPA (Churg-Strauss) | |
| Recurrent sinusitis + recurrent pneumonia + immunoglobulin deficiency | CVID, IgA deficiency |
| Clue | Points Toward |
|---|---|
| Bilateral vs unilateral | Bilateral = inflammatory (rhinosinusitis, allergic rhinitis); Unilateral = structural, foreign body, fungal ball, malignancy (NPC!) |
| Duration < 10 d | Viral URTI |
| Duration ≥10 d or double sickening | ABRS |
| Duration > 12 weeks | CRS |
| Itching, sneezing, conjunctival symptoms | Allergic rhinitis |
| Blood-stained discharge + neck mass | NPC (HK!) |
| Facial pain worse bending forward | Sinusitis |
| Lancinating/electric pain, trigger zones | Trigeminal neuralgia |
| Autonomic features (lacrimation, nasal congestion) + excruciating periorbital pain | Cluster headache |
| Nausea, photophobia, phonophobia | Migraine |
| Proptosis, ophthalmoplegia | Orbital cellulitis (complication) |
| Saddle-nose deformity, haemoptysis, haematuria | GPA |
| Black eschar, immunocompromised | Invasive fungal sinusitis |
High Yield Summary – Differential Diagnosis of Sinusitis
-
Most common DDx to rule out: Viral URTI (common cold) — self-limiting, < 10 d, not worsening. Bacterial RS is rare (0.5–2%) and diagnosed by duration ≥10 d, severe onset, or double sickening.
-
Most commonly misdiagnosed as sinusitis: Migraine — up to 80–90% of "sinus headaches" are actually migraine. Look for nausea, photophobia, and phonophobia (not features of sinusitis).
-
Must-not-miss in HK: NPC — unilateral nasal obstruction, blood-stained post-nasal drip, unilateral hearing loss/tinnitus, neck mass, cranial nerve palsies. Check EBV DNA.
-
Preseptal vs orbital cellulitis: Orbital cellulitis = ophthalmic emergency (proptosis, ophthalmoplegia, visual impairment). Most commonly from ethmoid sinusitis via lamina papyracea.
-
Syndromic patterns: Kartagener (sinusitis + bronchiectasis + situs inversus), CF (sinusitis + polyps + steatorrhoea), Samter's triad (CRSwNP + asthma + aspirin sensitivity), GPA (sinusitis + lung + kidney).
-
Unilateral nasal symptoms = red flag: Think foreign body (children), fungal ball, odontogenic sinusitis, malignancy (NPC, inverted papilloma, SCC).
Active Recall - Differential Diagnosis of Sinusitis
References
[1] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (Sinusitis slides, p14–15) [2] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (DDx of URTI section, p120–122; Sinusitis section, p137–139) [3] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (DDx of URTI section, p96; Sinusitis diagnosis, p109–113) [4] Senior notes: Ryan Ho Respiratory.pdf (Rhinosinusitis section, p54) [5] Senior notes: Adrian Lui Pediatrics Notes.pdf (Sinusitis section, p159) [6] Senior notes: Ryan Ho Neurology.pdf (Headache DDx, p57–58) [7] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (NPC clinical manifestation, p251) [8] Senior notes: Ryan Ho Urogenital.pdf (Nephritic syndrome evaluation — GPA triad, p63) [9] Senior notes: Ryan Ho Opthalmology.pdf (Orbital cellulitis, p37) [10] Senior notes: Maksim Medicine Notes.pdf (CNS infections, p194–196) [11] Senior notes: Maksim Medicine Notes.pdf (Bronchiectasis aetiology — syndromic associations, p301–303)
Diagnostic Criteria, Algorithm, and Investigations for Sinusitis (Rhinosinusitis)
Before diving into criteria and investigations, understand the foundational principle:
Diagnosis of rhinosinusitis is predominantly clinical [4][5]. The vast majority of patients with acute rhinosinusitis (ARS) do not need any imaging or laboratory investigations. The diagnosis is made at the bedside from history and physical examination. Investigations are reserved for:
- Suspected complications (orbital, intracranial)
- Chronic rhinosinusitis requiring objective confirmation
- Failure to respond to appropriate treatment
- Recurrent episodes suggesting an underlying predisposing factor
Only 2% of all episodes of viral URI are complicated by bacterial transformation, and yet antibiotics are VERY commonly ( > 85%) prescribed for patients presenting with sinusitis symptoms [4]. This underscores why rigorous diagnostic criteria exist — to prevent inappropriate antibiotic use.
2. Diagnostic Criteria
This is the standard used in HKUMed teaching and is directly from the CFB lecture slides:
Inflammation of the nose and the paranasal sinuses characterised by ≥2 symptoms, 1 of which should be either nasal blockage/obstruction/congestion or nasal discharge (anterior/posterior nasal drip), ± facial pain/pressure, ± reduction or loss of smell [1]
AND either:
- Endoscopic signs of nasal polyps, and/or mucopurulent discharge primarily from middle meatus and/or oedema/mucosal obstruction primarily in middle meatus
- AND/OR CT changes: mucosal changes within the ostiomeatal complex and/or sinuses [1]
Acute: < 12 weeks; Chronic: ≥12 weeks [1]
High Yield – EPOS 2020 Two-Part Diagnostic Criteria
The EPOS 2020 definition has TWO components:
- Symptom criteria: ≥2 symptoms (at least 1 nasal) ± facial pain ± hyposmia
- Objective criteria: Endoscopic OR CT findings
For acute rhinosinusitis in primary care, the symptom criteria alone are often sufficient because endoscopy/CT is not routinely done. For chronic rhinosinusitis, objective confirmation (endoscopy or CT) is required to avoid misdiagnosis (e.g., migraine misdiagnosed as CRS). [1]
Criteria: sudden onset of ≥2 of (with ≥1 nasal symptom) [4][5]:
- Nasal blockage/congestion or nasal discharge PLUS
- Facial pain/pressure and/or ↓ or loss of smell [4][5]
This symptom-based definition is practical for primary care where endoscopy/CT is unavailable. It identifies ARS broadly (viral + bacterial).
The critical next step is determining whether ARS is viral (self-limiting, no antibiotics needed) or bacterial (may benefit from antibiotics). Three clinical patterns define acute bacterial rhinosinusitis (ABRS) [2][3]:
| Pattern | Description | Rationale |
|---|---|---|
| Pattern 1: Persistent | Persistent symptoms or signs of ARS lasting ≥10 days without evidence of clinical improvement [2][3] | Viral URTIs should show improvement by day 7–10. Failure to improve by day 10 suggests bacterial superinfection has occurred in the obstructed, stagnant sinus. |
| Pattern 2: Severe onset | Onset of severe symptoms: high fever AND purulent nasal discharge or facial pain for at least 3–4 consecutive days at the beginning of illness [2][3] | A typical viral URTI does not cause high fever with localised facial pain for multiple consecutive days at onset. This severity pattern from the start suggests primary bacterial infection rather than viral → bacterial evolution. |
| Pattern 3: Double sickening | Symptoms of a typical viral URTI that are slowly improving but worsen again with more severe symptoms and signs after 5–6 days [2][3] | The biphasic course is the hallmark of secondary bacterial superinfection — the initial viral illness was resolving, but bacteria colonised the inflamed, poorly-draining sinus, causing a second wave of inflammation. |
In contrast:
Acute viral rhinosinusitis: symptoms or signs of ARS < 10 days that are not worsening [2][3]
Some sources use a "scoring" approach. Criteria for bacterial rhinosinusitis: ≥3 of the following [4][5]:
- Double sickening
- Discoloured, purulent nasal discharge
- Severe, localised pain
- Fever > 38°C or ↑ESR/CRP [4][5]
These criteria complement the three clinical patterns above. They are useful for borderline cases where none of the three patterns is clearly met.
Exam Tip
Know BOTH sets of diagnostic criteria:
- The three clinical patterns (persistent ≥10 d, severe onset ≥3–4 d, double sickening) — used in AAO-HNS and IDSA guidelines
- The ≥3 of 4 criteria (double sickening, purulent discharge, severe localised pain, fever/↑inflammatory markers) — used in EPOS/AFP frameworks
Both approaches are valid and may appear in exam questions from different angles.
Same symptom criteria as ARS but lasting > 12 weeks [5], PLUS objective confirmation:
- Endoscopy: polyps, mucopurulent discharge from middle meatus, mucosal oedema
- AND/OR CT sinuses: mucosal thickening, opacification, air-fluid levels within the ostiomeatal complex and/or sinuses [1]
Why is objective confirmation required for CRS but not always for ARS? Because many conditions (migraine, tension headache, allergic rhinitis, TMJ dysfunction) cause chronic facial pressure/pain that patients self-diagnose as "sinus problems." Without endoscopic or radiological evidence of sinus disease, the diagnosis of CRS is unreliable. Studies show that up to 80–90% of patients labelled as having "chronic sinusitis" or "sinus headache" actually have migraine.
The following algorithm integrates the clinical approach from history through to investigation:
4. Physical Examination
Physical examination in rhinosinusitis serves two purposes: (1) supporting the clinical diagnosis, and (2) identifying complications or alternative diagnoses.
Anterior rhinoscopy findings:
- Diffuse mucosal oedema — inflammatory vasodilation and extravasation cause swollen, erythematous nasal mucosa
- Narrowing of middle meatus — oedematous uncinate process and middle turbinate encroach on the critical OMC drainage pathway
- Inferior turbinate hypertrophy — reactive mucosal engorgement; contributes to nasal obstruction
- Copious and purulent discharge — watery in viral/allergic; purulent (yellow-green) in bacterial/late viral, though colour alone is unreliable
Also look for:
More informative than anterior rhinoscopy — the gold standard for visualising the middle meatus, OMC, sphenoethmoidal recess, and nasopharynx.
Key findings:
- Mucopurulent discharge from middle meatus (maxillary/anterior ethmoid/frontal sinuses) or sphenoethmoidal recess (posterior ethmoid/sphenoid)
- Polyps: grey-white, translucent, mobile, insensitive to pain
- Mucosal oedema/obstruction in the middle meatus [1]
- Masses: must visualise the nasopharynx (especially in HK — NPC screening)
Endoscopic signs of nasal polyps, and/or mucopurulent discharge primarily from middle meatus and/or oedema/mucosal obstruction primarily in middle meatus — one of the objective criteria in the EPOS 2020 definition [1]
Indicated in patients with symptoms of ear pain, fullness or pressure, hearing loss or tinnitus [2][3]. This evaluates for:
- Middle ear effusion (serous otitis media) — from Eustachian tube dysfunction secondary to rhinosinusitis
- Tympanic membrane retraction — negative middle ear pressure due to Eustachian tube obstruction
- Acute otitis media — coexisting or alternative diagnosis, especially in children
- Palpation and percussion of sinus areas (frontal, maxillary, ethmoidal) — tenderness supports sinusitis but is not diagnostic in isolation [4][5]
- Transillumination — opacification of maxillary/frontal sinus upon transillumination [4][5] — largely historical; low sensitivity and specificity
- Periorbital examination — oedema, erythema, proptosis, ophthalmoplegia → complications
- Oral cavity — dental caries, periapical tenderness → odontogenic sinusitis; palatal eschar → mucormycosis
- Neck — lymphadenopathy → NPC, lymphoma
5. Investigations
| Clinical Scenario | Investigation Needed? |
|---|---|
| Uncomplicated ARS (viral or bacterial) | NOT indicated — Imaging is NOT indicated if uncomplicated [4][5]. Clinical diagnosis suffices. |
| Suspected complications | CT sinuses with contrast (urgent) ± MRI |
| Failure to respond to appropriate treatment | CT sinuses, consider ENT referral, C/ST |
| Chronic rhinosinusitis | Nasal endoscopy + CT sinuses (objective confirmation required) |
| Recurrent ARS | CT sinuses, allergy testing, immune workup |
| Unilateral symptoms / suspicion of malignancy | Nasal endoscopy + biopsy, CT/MRI, EBV DNA (HK) |
5.2 Imaging
Plain films may show sinus fluid levels in patients [2][3].
| Finding | Interpretation |
|---|---|
| Air-fluid level | Fluid (pus/transudate) within a sinus — most specific finding for acute sinusitis |
| Sinus opacification | Complete opacification suggests significant mucosal disease, retained secretions, or mass |
| Mucosal thickening | Mucosal swelling > 4–6 mm is considered abnormal |
- Poor sensitivity and specificity → NOT recommended [4][5]
- Poor visualization of ethmoid sinuses leads to high false-negative rates [2][3] — the ethmoid air cells are superimposed on other structures on plain X-ray, making interpretation unreliable
- Cannot evaluate the OMC
- Cannot assess for complications (orbital, intracranial)
- Largely superseded by CT in current practice; may still be used in resource-limited settings
Why is sinus X-ray poor? Because the sinuses are three-dimensional structures surrounded by complex bony anatomy. A two-dimensional X-ray projection superimposes these structures, making subtle mucosal thickening, early opacification, or ethmoid disease invisible. CT provides cross-sectional imaging that eliminates this superimposition.
CT sinuses — preferred imaging modality [2][3].
Non-contrast CT sinuses (coronal and axial sections):
| Finding | Interpretation | Pathophysiological Basis |
|---|---|---|
| Air-fluid levels [2][3][4][5] | Acute sinusitis with retained secretions/pus; fluid settles dependently within the sinus when upright | Ostial obstruction traps inflammatory exudate within the sinus cavity |
| Mucosal oedema and thickening [2][3][4][5] | Inflammatory swelling of the pseudostratified ciliated epithelium | Vascular engorgement + inflammatory exudate in the subepithelial space |
| Air bubbles within sinuses [2][3][4][5] | Suggests active infection with gas-producing bacteria or partial drainage | Gas trapped within purulent secretions |
| Opacification [2][3][4][5] | Complete filling of sinus with soft tissue density — mucosal disease, retained secretions, polyps, fungal ball, or tumour | Severe mucosal hypertrophy + secretion accumulation |
| OMC obstruction | Mucosal thickening/oedema at the infundibulum, hiatus semilunaris, or frontal recess | Critical for surgical planning — FESS targets the OMC to restore drainage |
| Bone erosion / destruction | Concerning for malignancy, invasive fungal sinusitis, or osteomyelitis | Tumour infiltration, angioinvasive fungi, or chronic osteitis |
| Hyperdense material | Calcification or desiccated secretions within sinus; characteristic of fungal ball (mycetoma) or AFRS | Inspissated allergic mucin (AFRS) or fungal calcification |
| CT changes: mucosal changes within the ostiomeatal complex and/or sinuses [1] | One of the objective criteria for EPOS 2020 CRS diagnosis | Confirms structural/inflammatory sinus disease |
CT sinuses with contrast [2][3]:
- CT with contrast is required to identify complications of sinusitis and evaluate disease location and extent of involvement beyond the sinuses [2][3]
- Contrast enhancement helps delineate:
- Orbital complications: rim-enhancing subperiosteal abscess along medial orbital wall, orbital abscess, preseptal vs post-septal collection
- Intracranial complications: epidural/subdural empyema (rim enhancement), cerebral abscess, cavernous sinus thrombosis (filling defect in cavernous sinus, "delta sign" with superior sagittal sinus thrombosis)
- Bone involvement: osteomyelitis, Pott's puffy tumour
Lund-Mackay Scoring System (CT-based grading for CRS):
- Used to quantify disease burden on CT — grades each sinus (0 = clear, 1 = partial opacification, 2 = total opacification) and the OMC (0 = patent, 2 = obstructed) bilaterally
- Maximum score = 24 (12 per side)
- Useful for surgical decision-making and research; a score > 0 is present in up to 42% of asymptomatic individuals, so it must be interpreted in clinical context
When to Order CT Sinuses
Acute: Only when complications are suspected (periorbital swelling, neurological signs, systemic toxicity) or when the patient fails to respond to appropriate treatment.
Chronic: Part of the diagnostic workup to confirm CRS objectively and to plan FESS if indicated. Get CT AFTER maximal medical therapy (INCS + saline irrigation ± antibiotics) to see residual disease.
Never: Routine uncomplicated ARS — imaging adds cost without changing management.
MRI sinuses: useful to delineate extent of soft tissue involvement in patients who have complications of acute rhinosinusitis [2][3].
| Advantage | When to Use |
|---|---|
| Superior soft tissue contrast | Orbital complications (differentiating orbital cellulitis from abscess, delineating extent of inflammation) |
| Distinguishes tumour from retained secretions | Suspected malignancy (NPC, sinonasal carcinoma); tumour enhances with gadolinium, retained secretions do not |
| Intracranial complications | Cerebral abscess, subdural empyema, cavernous sinus thrombosis (MR venography) |
| No ionising radiation | Preferred in children when repeated imaging is needed |
| Evaluates perineural and dural spread | Tumour staging (NPC, skull base tumours) |
Limitations: Poor bone detail (CT is better for bony anatomy, OMC assessment, surgical planning); more expensive; longer acquisition time; contraindicated with certain implants.
Practical rule: CT for bone, surgical planning, and initial acute complication assessment; MRI for soft tissue delineation, tumour characterisation, and intracranial extension.
5.3 Laboratory Investigations
| Test | When Indicated | Interpretation |
|---|---|---|
| CBC with differential | Suspected bacterial infection, systemic toxicity, immunocompromise | Leukocytosis with neutrophilia → bacterial infection; Eosinophilia → allergic component, AFRS, EGPA |
| ESR / CRP | Part of bacterial criteria: fever > 38°C or ↑ESR/CRP [4][5] | Elevated in bacterial sinusitis; very high CRP → severe bacterial infection or complication |
| Blood cultures | Systemic toxicity, high fever, suspected intracranial complication | Identify bacteraemia / guide antibiotic therapy |
| EBV DNA, EBV VCA-IgA | Suspected NPC (unilateral symptoms, bloody discharge, neck mass — HK context) | Elevated levels warrant nasopharyngoscopy + biopsy |
| ANCA, ANA, anti-dsDNA | Suspected autoimmune/vasculitic sinusitis (destructive, bloody crusting, systemic features) | c-ANCA/PR3 → GPA; p-ANCA/MPO → EGPA; ANA/anti-dsDNA → SLE |
| Immunoglobulins (IgG, IgA, IgM, IgG subclasses) | Recurrent sinusitis, recurrent infections, failure to respond to treatment | Hypogammaglobulinaemia → CVID, IgA deficiency |
| HIV testing | Recurrent/unusual sinusitis, opportunistic infections | Immunodeficiency as underlying cause |
| Serum total IgE, specific IgE | Allergic component, suspected AFRS | ↑Total IgE → atopy; specific IgE → identify allergens |
Sinus aspirate or endoscopic culture of middle meatus [2][3][4][5]:
- NOT routinely required in diagnosis of ARS and is not commonly available [2][3]
- Reasonable to obtain in patients in whom there is a suspicion of intracranial extension of infection or other serious complication [2][3]
- Only when there is suspicion of serious complications [4][5]
| Method | Description | When Used |
|---|---|---|
| Sinus aspiration (gold standard) | Direct needle puncture of the sinus (usually maxillary via inferior meatus or canine fossa) to aspirate contents for C/ST | Rarely performed; reserved for complicated cases, immunocompromised patients, treatment failure, or research. Considered the gold standard because it avoids contamination from nasal flora. |
| Endoscopically-directed middle meatus swab | Culture taken from the middle meatus under endoscopic guidance | More practical than aspiration; good correlation with maxillary sinus aspirate in studies (~80–85% concordance). Used when culture guidance is needed (treatment failure, complicated cases). |
| Nasopharyngeal swab | Swab of the nasopharynx | NOT reliable for sinusitis — nasopharyngeal flora does not necessarily reflect sinus pathogens. More useful for viral/pertussis testing. |
| Tissue biopsy | Endoscopic biopsy of nasal/sinus mucosa or mass | Indicated for suspected malignancy (NPC, SCC), granulomatous disease (GPA, sarcoidosis), or invasive fungal sinusitis (Mucormycosis — histology shows broad, non-septate, ribbon-like hyphae with angioinvasion) |
| Test | Method | Indication |
|---|---|---|
| Skin prick test | Allergen applied to forearm skin, positive if wheal ≥3 mm | First-line for IgE-mediated allergy; identifies triggers for allergic rhinitis underlying CRS |
| Serum-specific IgE (ImmunoCAP/RAST) | Blood test measuring allergen-specific IgE | When skin prick testing is impractical (dermatographism, antihistamine use, extensive eczema) |
| Nasal cytology / smear | Nasal secretion or scraping examined for eosinophils | Eosinophilia supports allergic or eosinophilic CRS (CRSwNP, AFRS, EGPA) |
| Investigation | Indication | Interpretation |
|---|---|---|
| Saccharin test / Mucociliary clearance test | Suspected PCD / ciliary dyskinesia | Measures time for saccharin placed on inferior turbinate to be tasted → normal < 20 min; prolonged → impaired mucociliary clearance |
| Nasal NO measurement | Screening for PCD | Very low nasal NO is characteristic of PCD (cilia produce NO; absent/dysfunctional cilia → ↓NO production) |
| Sweat chloride test | Suspected cystic fibrosis (children with CRS + polyps, recurrent infections, failure to thrive) | Sweat Cl⁻ > 60 mmol/L diagnostic of CF |
| OPG (orthopantomogram) | Suspected odontogenic sinusitis | Periapical lucency, root canal pathology, oroantral fistula |
| Pulmonary function tests | CRSwNP with suspected asthma (Samter's triad) | FEV₁/FVC < 0.7 with reversibility → concomitant asthma |
| β₂-transferrin | Clear unilateral discharge — CSF leak? | Positive β₂-transferrin = CSF rhinorrhoea (skull base defect) |
| Scenario | Key Investigations | Rationale |
|---|---|---|
| Uncomplicated ARS | None — clinical diagnosis | Imaging and labs add no value; most cases are viral and self-limiting |
| Suspected ABRS, uncomplicated | Consider ESR/CRP only if diagnosis uncertain | Supports bacterial criteria (≥3 of 4); CBC if systemically unwell |
| Suspected complication (orbital/intracranial) | CT sinuses WITH contrast (urgent), CBC, CRP, blood cultures; ± MRI | CT delineates abscess, bone destruction, intracranial extension; MRI for soft tissue detail |
| CRS workup | Nasal endoscopy, CT sinuses (non-contrast, after maximal medical therapy), allergy testing, CBC/eosinophils | Objective confirmation, identify polyps, plan FESS, phenotype inflammation |
| Recurrent ARS | CT sinuses, allergy testing, immunoglobulins, HIV, sweat chloride (children), saccharin test | Identify predisposing anatomical, allergic, or immune factors |
| Unilateral symptoms / bloody discharge (HK) | Nasal endoscopy + biopsy, CT/MRI nasopharynx, EBV DNA | Exclude NPC until proven otherwise |
| Immunocompromised with sinusitis | CT sinuses, urgent nasal endoscopy + biopsy, blood cultures, tissue culture/histology | Exclude invasive fungal sinusitis (Mucormycosis, Aspergillosis) — tissue biopsy is critical |
| Feature | Sinus X-ray | CT Sinuses | MRI Sinuses |
|---|---|---|---|
| Sensitivity | Poor [2][3][4][5] | High | High (for soft tissue) |
| Specificity | Poor [4][5] | Moderate-High | High |
| Bone detail | Moderate | Excellent | Poor |
| Soft tissue detail | Poor | Moderate | Excellent |
| OMC assessment | Not possible | Excellent | Moderate |
| Complication assessment | Not possible | Good (with contrast) [2][3] | Best (with gadolinium) [2][3] |
| Radiation | Low | Moderate | None |
| Cost | Low | Moderate | High |
| Availability | High | High | Moderate |
| Current recommendation | NOT recommended [4][5] | Preferred imaging modality [2][3] | Reserved for complications/tumour |
High Yield Summary – Diagnosis of Sinusitis
-
Rhinosinusitis is a clinical diagnosis — no imaging needed for uncomplicated ARS.
-
EPOS 2020 criteria: ≥2 symptoms (1 nasal) + objective evidence (endoscopy or CT). Acute < 12 wk, Chronic ≥12 wk.
-
Three patterns for ABRS: (1) Persistent ≥10 d no improvement, (2) Severe onset ≥3–4 d, (3) Double sickening after 5–6 d.
-
Alternative bacterial scoring: ≥3 of — double sickening, purulent discharge, severe localised pain, fever > 38°C or ↑ESR/CRP.
-
Sinus X-ray: Poor sensitivity and specificity → NOT recommended. Poor ethmoid visualisation → high FN rates.
-
CT sinuses: Preferred imaging modality. Findings: air-fluid levels, mucosal oedema/thickening, air bubbles, opacification. With contrast for complications.
-
MRI: Best for soft tissue detail — complications, tumour characterisation, intracranial extension.
-
Sinus aspirate / endoscopic C/ST: NOT routine. Only for suspected serious complications, treatment failure, or immunocompromised.
-
CRS workup: Nasal endoscopy + CT sinuses (after maximal medical therapy) + allergy testing + eosinophils.
-
HK context: Unilateral bloody discharge → endoscopy + biopsy + EBV DNA to exclude NPC.
Active Recall - Diagnosis and Investigation of Sinusitis
References
[1] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (Sinusitis definition and EPOS 2020 criteria, p14–15) [2] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (Sinusitis diagnosis, p137–139) [3] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (Sinusitis diagnosis, p113) [4] Senior notes: Ryan Ho Respiratory.pdf (Rhinosinusitis, p54) [5] Senior notes: Adrian Lui Pediatrics Notes.pdf (Sinusitis, p159)
Management of Sinusitis (Rhinosinusitis)
Before discussing specific treatments, several foundational principles guide rhinosinusitis management:
- Routine use of antibiotics does NOT prevent development of complications [4][5]. Most ARS is viral, self-limiting, and does not benefit from antibiotics. Antibiotic overuse drives resistance and adverse effects.
- The goal of treatment differs by type:
- Acute viral RS: Symptom relief while the immune system clears the virus
- Acute bacterial RS: Shorten symptom duration and prevent (rare) complications
- Chronic RS: Control inflammation (not primarily infection) and restore sinus drainage
- Stepwise approach: Supportive care first → antibiotics only if bacterial criteria met → surgery only if medical therapy fails or complications arise.
- Management of CRS leans towards anti-inflammatory agents as it is predominantly due to complex inflammatory changes rather than persistent bacterial infection [5].
3. Management of Acute Rhinosinusitis
3.1 Acute Viral Rhinosinusitis (Majority of Cases)
Symptomatic Tx: regular analgesia, NS irrigation, nasal decongestants [4][5]
Treatments (from CFB lecture slides): nasal saline irrigation, nasal decongestant [1]
| Treatment | Mechanism | Evidence / Rationale | Practical Points |
|---|---|---|---|
| Regular analgesia (paracetamol, NSAIDs) | Paracetamol: central COX inhibition → ↓prostaglandin-mediated pain and fever. NSAIDs: peripheral + central COX inhibition → ↓inflammation, pain, fever. | Proven effective for symptom relief (facial pain, headache, fever). Do NOT shorten duration of viral URI [12]. Paracetamol is proven effective and safe. NSAIDs: more effective but ↑side effects, avoided if (1) not eating well (GI side effects) (2) aspirin-sensitive asthma (3) renal dysfunction (4) children due to risk of Reye syndrome [12]. | Paracetamol: 500 mg–1 g QDS (adults). Ibuprofen: 400 mg TDS (adults). Avoid aspirin in children < 16 y/o. |
| Nasal saline irrigation [1][4][5] | Physically flushes mucus, crusts, allergens, and inflammatory mediators from the nasal cavity. Restores mucociliary clearance by rehydrating the sol layer of the mucociliary blanket. May directly reduce mucosal oedema (hypertonic saline draws fluid osmotically). | Strong evidence for symptom relief in both ARS and CRS. First-line adjunctive therapy. Isotonic (0.9% NaCl) or hypertonic (3% NaCl) saline — hypertonic may be slightly more effective but can cause temporary stinging. | Technique matters: high-volume, low-pressure irrigation (e.g., squeeze bottle, neti pot) is more effective than nasal spray. Head tilted forward, breathe through mouth, irrigate each nostril. |
| Nasal decongestant [1][4][5] | Topical (oxymetazoline, xylometazoline): α₁-adrenergic agonist → vasoconstriction of nasal mucosal blood vessels → ↓mucosal swelling → ↑airflow and drainage. Oral (pseudoephedrine): systemic α₁-agonist. | Rapid symptomatic relief of nasal obstruction. Does NOT treat underlying infection or inflammation. | Topical: Limit to ≤5–7 days to avoid rhinitis medicamentosa (rebound congestion from receptor down-regulation and compensatory vasodilation). Oral: avoid in uncontrolled hypertension, ischaemic heart disease, MAOIs, closed-angle glaucoma, urinary retention (BPH). |
Rhinitis Medicamentosa – Why Does It Happen?
Topical nasal decongestants work by stimulating α₁-adrenergic receptors on vascular smooth muscle → vasoconstriction. With prolonged use ( > 5–7 days), the receptors down-regulate (tachyphylaxis), and there is compensatory vasodilation with increased receptor sensitivity to endogenous vasodilators. The result: worsening nasal congestion that only temporarily improves with more decongestant, creating a vicious cycle of dependency. Treatment: abrupt cessation + INCS to bridge the rebound period.
± Intranasal steroids: modest benefit, to be used if symptoms persist [4][5]
| Drug Examples | Mechanism | Evidence | Practical Points |
|---|---|---|---|
| Fluticasone propionate, mometasone furoate, budesonide | Binds intracellular glucocorticoid receptor → suppresses NF-κB → ↓production of pro-inflammatory cytokines (IL-1, IL-6, TNF-α), ↓eosinophil/neutrophil recruitment, ↓mucosal oedema, ↓glandular secretion | Systematic reviews show modest symptom improvement in ARS when added to antibiotics or used alone. Greater benefit in allergic patients with concurrent allergic rhinitis. | Start early if symptoms persistent > 5–7 d. Takes 2–3 days for effect (not immediate). Spray technique: aim laterally (towards ipsilateral ear), avoid aiming at septum (risk of epistaxis, septal perforation with chronic use). Low systemic bioavailability (fluticasone < 1%, mometasone < 0.1%). |
| Treatment | Why NOT Recommended |
|---|---|
| Antibiotics | Viral RS — antibiotics are ineffective against viruses. Only 2% of viral URIs progress to bacterial sinusitis [4]. Antibiotic overuse → resistance, C. difficile, adverse drug reactions. |
| Oral antihistamines | No benefit in non-allergic ARS; may thicken secretions by drying (anticholinergic effect of first-generation antihistamines), impairing drainage. Only indicated if concurrent allergic rhinitis. |
| Mucolytics (guaifenesin) | Limited evidence of benefit; may thin secretions but no proven clinical impact. |
| Systemic corticosteroids | Generally not indicated for uncomplicated ARS. May be considered as a short course in severe facial pain refractory to other measures, but risks (hyperglycaemia, adrenal suppression, insomnia) generally outweigh benefits. |
| Zinc, vitamin C, echinacea | No convincing evidence for treatment (some weak evidence for zinc in prevention of common cold). |
3.2 Acute Bacterial Rhinosinusitis (ABRS)
Antibiotics if bacterial sinusitis only [4][5]. Oral antibiotics × 5–10 d [1] (CFB lecture slide).
In ABRS, criteria for antibiotic use (CFB lecture slides) [1]:
- Fever ≥38°C
- Double sickening
- Unilateral disease
- Severe pain
- Raised ESR/CRP
This correlates with the previously discussed diagnostic criteria for ABRS. The decision to prescribe antibiotics should be based on meeting ABRS diagnostic criteria — not merely on the presence of coloured nasal discharge.
Two reasonable strategies exist for confirmed ABRS:
- Immediate antibiotics — appropriate if severe symptoms (high fever, severe pain) or immunocompromised
- Watchful waiting (delayed prescription) — give a prescription to use only if no improvement in 48–72 h, or symptoms worsen. Appropriate for mild-moderate ABRS in immunocompetent adults. Studies show ~65–80% of ABRS resolves spontaneously without antibiotics.
| Line | Drug | Dose / Duration | Rationale | When to Use |
|---|---|---|---|---|
| First-line | Amoxicillin [4][5] | Adults: 500 mg TDS or 1 g TDS (high-dose) × 5–10 days [1][4][5] | Covers the three main pathogens: S. pneumoniae, H. influenzae (non-β-lactamase producing), M. catarrhalis (partially). Good tissue penetration into sinuses. Narrow spectrum. Cheap. Well-tolerated. | Uncomplicated ABRS, first episode, no recent antibiotic use, no penicillin allergy |
| High-dose amoxicillin | Amoxicillin | 90 mg/kg/day (paediatric), 2 g TDS (adult) | Overcomes intermediate penicillin-resistant S. pneumoniae by achieving higher concentrations at the sinus mucosal level (the time-dependent bactericidal activity of β-lactams means higher concentrations → more time above MIC) | Areas with high prevalence of penicillin-intermediate S. pneumoniae (relevant to HK), daycare attendance, recent antibiotic use, immunocompromised |
| Second-line | Amoxicillin-clavulanate (co-amoxiclav) | Adults: 625 mg TDS or augmentin 1 g BD × 5–10 d | Clavulanate is a β-lactamase inhibitor → extends coverage to β-lactamase producing H. influenzae and M. catarrhalis. Also covers anaerobes (useful if odontogenic sinusitis suspected). | Failure of first-line amoxicillin at 48–72 h; β-lactamase producing organisms suspected; odontogenic sinusitis |
| Penicillin-allergic (non-anaphylactic) | Cephalosporins (cefuroxime, cefpodoxime) | Cefuroxime 250–500 mg BD × 5–10 d | 2nd/3rd generation cephalosporins cover similar spectrum. Cross-reactivity with penicillin is < 2% (much lower than previously thought). | Mild penicillin allergy (rash only, no anaphylaxis) |
| Penicillin-allergic (anaphylactic) | Respiratory fluoroquinolone (levofloxacin, moxifloxacin) | Levofloxacin 500 mg daily × 5–7 d; Moxifloxacin 400 mg daily × 5 d | Excellent sinus penetration, broad coverage of respiratory pathogens including resistant S. pneumoniae. BUT: reserved as last-line due to serious adverse effects. | Severe penicillin allergy with anaphylaxis/angioedema; failure of multiple courses |
| Penicillin-allergic (alternative) | Doxycycline | 100 mg BD × 5–10 d | Covers S. pneumoniae and H. influenzae. Not first-line due to resistance variability. | Adult penicillin-allergic patients; contraindicated in children < 8 y/o and pregnant women (teeth discolouration, bone growth inhibition) |
| Macrolides | Azithromycin, clarithromycin | Azithromycin 500 mg day 1, then 250 mg days 2–5 | NOT recommended as first-line due to high rates of macrolide-resistant S. pneumoniae (~30–40% in many regions). | Only if no other options; local susceptibility data should guide |
Why Amoxicillin First?
Amoxicillin is first-line because it:
- Covers the main pathogen (S. pneumoniae) — which causes the most severe disease
- Has excellent sinus tissue penetration — achieves high concentrations in sinus mucosa
- Is narrow-spectrum — minimises collateral damage to commensal flora, reducing C. difficile risk
- Is cheap and well-tolerated
- Can overcome intermediate penicillin resistance when given at high doses
You only "escalate" to amoxicillin-clavulanate when you suspect β-lactamase-producing H. influenzae or M. catarrhalis (treatment failure, recent antibiotic exposure), or when odontogenic sinusitis is suspected (anaerobic coverage needed).
Fluoroquinolone Cautions
Respiratory fluoroquinolones (levofloxacin, moxifloxacin) should be reserved as last-line agents due to serious adverse effects:
- Tendon rupture (Achilles tendon — risk increases with concurrent corticosteroid use, age > 60, renal impairment)
- QT prolongation (moxifloxacin > levofloxacin) → risk of torsades de pointes
- CNS effects (insomnia, confusion, seizures)
- Aortic dissection/aneurysm (rare but FDA black box warning)
- Peripheral neuropathy
- C. difficile infection
- Contraindicated in: children/adolescents (cartilage toxicity), pregnancy/breastfeeding, myasthenia gravis (exacerbation), concurrent QT-prolonging drugs
- 5–10 days is the standard range [1][4][5]
- Shorter courses (5 days) are as effective as longer courses (10–14 days) for uncomplicated ABRS in adults (evidence supports non-inferiority)
- Children: typically 10–14 days (data on short courses in children is less robust)
- Continue for 7 days after clinical improvement in complicated cases
All the supportive measures used for viral ARS should continue alongside antibiotics:
- Nasal saline irrigation
- Nasal decongestant (≤5–7 days)
- Regular analgesia
- ± INCS
- Expect clinical improvement within 48–72 hours of starting antibiotics
- If no improvement → reassess diagnosis (is it really bacterial? consider alternative diagnoses), check compliance, consider resistant organism, switch to second-line antibiotic
- If still no improvement after second-line → CT sinuses, ENT referral, consider sinus aspirate for C/ST
4. Management of Chronic Rhinosinusitis (CRS)
CRS management leans towards anti-inflammatory agents as it is predominantly due to complex inflammatory changes rather than persistent bacterial infection [5].
| Treatment | Details | Mechanism / Rationale |
|---|---|---|
| Intranasal corticosteroids (INCS) — CORNERSTONE | Fluticasone propionate 2 sprays each nostril BD, or mometasone furoate 2 sprays each nostril daily. Trial of topical INCS for 8–12 weeks [5]. | The single most effective medical therapy for CRS. Suppresses the chronic inflammatory process (regardless of whether CRSsNP or CRSwNP). In CRSwNP, INCS can shrink polyps and prevent regrowth. Minimal systemic absorption (fluticasone < 1% bioavailability). |
| Nasal saline irrigation | Large-volume irrigation (240 mL, squeeze bottle) BD | Mechanical debridement of mucus, crusts, inflammatory mediators. Restores mucociliary function. Synergistic with INCS (removes mucus layer → better steroid deposition). First-line adjunct in all CRS. |
| Short course of oral antibiotics | Amoxicillin-clavulanate or doxycycline × 2–4 weeks | May be useful for acute exacerbations of CRS or as part of initial maximal medical therapy. Doxycycline has anti-inflammatory properties (inhibits matrix metalloproteinases) in addition to antibacterial effects, making it particularly useful in CRSwNP. |
| Long-term low-dose macrolides | Clarithromycin 250 mg daily or azithromycin 250 mg 3×/week × 3 months | Anti-inflammatory and immunomodulatory effects (not primarily antibacterial at these doses): ↓IL-8, ↓neutrophil chemotaxis, ↓mucus hypersecretion, ↓biofilm formation. Evidence supports benefit in CRSsNP (neutrophilic phenotype) more than CRSwNP. Monitor for QT prolongation, hearing loss, hepatotoxicity. |
| Short course of oral corticosteroids | Prednisolone 0.5 mg/kg/day × 1–2 weeks, tapering | Potent anti-inflammatory → rapidly shrinks nasal polyps and reduces mucosal oedema. Used as a "rescue" course in CRSwNP before reassessment or surgery. Risks with repeated courses: adrenal suppression, osteoporosis, hyperglycaemia, avascular necrosis, cataracts, immunosuppression. |
| Topical antibiotic irrigation | Mupirocin or gentamicin in saline irrigation | Used in refractory CRS with positive cultures (especially S. aureus). Delivers high local antibiotic concentration with minimal systemic absorption. Limited evidence but used in some tertiary centres. |
| Leukotriene receptor antagonists | Montelukast 10 mg daily | Blocks cysteinyl leukotriene receptor (CysLT₁) → ↓eosinophilic inflammation. Particularly useful in CRSwNP with concurrent asthma and AERD/Samter's triad (where leukotriene overproduction is central to pathophysiology). |
| Antihistamines | Oral: cetirizine, loratadine; Intranasal: azelastine | Only indicated if concurrent allergic rhinitis is present. No benefit in non-allergic CRS. |
The advent of biologic therapies has revolutionised the management of severe, recurrent CRSwNP refractory to conventional therapy. These are monoclonal antibodies targeting specific components of the Type 2 inflammatory pathway:
| Biologic | Target | Mechanism | Indication |
|---|---|---|---|
| Dupilumab | IL-4Rα subunit (blocks both IL-4 and IL-13 signalling) | ↓Th2 inflammation, ↓eosinophil recruitment, ↓mucus production, ↓polyp oedema | Severe CRSwNP refractory to INCS + oral steroids + FESS. Also indicated for concurrent severe asthma and atopic dermatitis (triple benefit). FDA/EMA approved for CRSwNP. |
| Omalizumab | IgE (anti-IgE) | Neutralises free IgE → prevents IgE-mediated mast cell degranulation | CRSwNP with elevated IgE and concurrent allergic asthma |
| Mepolizumab | IL-5 | ↓Eosinophil production and survival | Severe eosinophilic CRSwNP with concurrent eosinophilic asthma |
| Benralizumab | IL-5Rα | Direct eosinophil depletion via ADCC (antibody-dependent cell cytotoxicity) | Similar to mepolizumab but works via direct eosinophil killing rather than just blocking IL-5 |
These biologics represent a paradigm shift — moving from blunt immunosuppression (oral steroids) to precision targeting of the specific inflammatory pathway. They are expensive and reserved for severe, refractory disease. However, for patients with Samter's triad or severe eosinophilic CRSwNP who have had multiple FESS procedures with polyp recurrence, biologics can dramatically improve quality of life.
4.3 Surgical Management
| Aspect | Details |
|---|---|
| Principle | Endoscopic removal of diseased tissue and widening of sinus ostia to restore natural drainage pathways. "Functional" because the goal is to restore physiology, not to strip all mucosa. |
| Indications | (1) CRS refractory to maximal medical therapy (INCS + saline ± antibiotics × 8–12 weeks). (2) Nasal polyposis refractory to medical therapy. (3) Complications of ARS (e.g., orbital abscess requiring drainage). (4) Fungal ball. (5) Mucocoele. (6) Recurrent ARS with anatomical obstruction. |
| Key steps | Uncinectomy (removal of uncinate process) → maxillary antrostomy (widen natural ostium) → ethmoidectomy (anterior ± posterior) → ± frontal sinusotomy (Draf procedure) → ± sphenoidotomy |
| CT role | Pre-operative CT sinuses (non-contrast, fine-cut coronal) is mandatory for surgical planning — maps the anatomy, identifies dangerous variants (e.g., dehiscent lamina papyracea, low-lying skull base/fovea ethmoidalis, Onodi cell near optic nerve) |
| Complications | Orbital injury (lamina papyracea breach → orbital haematoma, extraocular muscle damage, optic nerve injury → blindness), CSF leak (cribriform plate breach), haemorrhage (anterior ethmoidal artery, sphenopalatine artery), synechia (adhesions), recurrence of polyps |
| Post-operative care | Nasal saline irrigation (essential), INCS (to prevent polyp recurrence), regular endoscopic debridement in clinic |
| Procedure | Indication |
|---|---|
| Balloon sinuplasty | Minimally invasive dilation of sinus ostia using a balloon catheter. Useful for isolated maxillary or frontal sinusitis without polyps. Less tissue removal than FESS. |
| Caldwell-Luc operation | Open approach to maxillary sinus via canine fossa incision. Largely historical; still used for access in difficult cases (odontogenic sinusitis, maxillary sinus tumours). |
| External drainage [1] | External drainage approach (from CFB lecture slide, p20) — may be required for complicated sinusitis with abscess formation (e.g., frontal sinus trephination for frontal sinusitis with Pott's puffy tumour, or external ethmoidectomy for orbital abscess). |
| Septoplasty / turbinate reduction | If deviated septum or turbinate hypertrophy is contributing to OMC obstruction and recurrent sinusitis |
5. Management of Complicated Sinusitis
Complications require urgent, aggressive management — delay can result in blindness, permanent neurological deficit, or death.
Urgent consult ophthalmologist and ENT [9]:
In practice, should urgent consult ENT and do imaging first before consulting EYE. Reason: blindness from orbital cellulitis is NOT very common but patient might die from intracranial spread if underlying sinus infection not treated promptly [9].
| Step | Details |
|---|---|
| Imaging | Emergency CT/MRI — shows EOM inflammation, fat stranding, anterior displacement of globe, ± evidence of ethmoid sinusitis, ± subperiosteal/orbital abscesses [9] |
| Blood cultures | Blood culture before empirical antibiotics [9] |
| IV antibiotics | High dose IV antibiotics if uncomplicated. Covers both G+ and G- organisms (anaerobe if intracranial extension). Usually IV vancomycin + ceftriaxone, cefotaxime, tazocin or unasyn [9] |
| Surgical drainage | Surgical biopsy if poor response to antibiotics for C/ST. Surgical drainage if large abscess [9]. Indications for urgent surgery: subperiosteal abscess ≥ 10 mm, orbital abscess, no improvement within 24–48 h of IV antibiotics, visual deterioration. |
Why vancomycin? Because MRSA is a concern in orbital/intracranial infections, and the consequences of inadequate coverage are devastating. Vancomycin covers MRSA and other resistant Gram-positives. Combined with a 3rd-gen cephalosporin (ceftriaxone) or β-lactam/β-lactamase inhibitor (tazocin/unasyn) for Gram-negative and anaerobic coverage.
| Chandler Classification of Orbital Complications | Description | Management |
|---|---|---|
| Stage I: Preseptal cellulitis | Infection anterior to orbital septum; no orbital involvement | Oral antibiotics (amoxicillin-clavulanate or cephalosporin); close monitoring; upgrade to IV if worsening |
| Stage II: Orbital cellulitis | Diffuse infection of orbital fat; no abscess | IV antibiotics; serial ophthalmological assessment; imaging |
| Stage III: Subperiosteal abscess | Pus between periorbita and bone | IV antibiotics + surgical drainage (endoscopic or external) |
| Stage IV: Orbital abscess | Pus within orbital fat | IV antibiotics + surgical drainage (ophthalmic/ENT) |
| Stage V: Cavernous sinus thrombosis | Bilateral orbital signs, CN palsies, sepsis | IV antibiotics + anticoagulation (controversial but commonly used) + manage source |
| Complication | Management |
|---|---|
| Meningitis | IV antibiotics (ceftriaxone + vancomycin ± ampicillin for Listeria coverage if elderly/immunocompromised) + dexamethasone (before or with first antibiotic dose in bacterial meningitis) + source control (FESS for sinus source) |
| Brain abscess / subdural empyema | IV antibiotics (ceftriaxone + metronidazole ± vancomycin) + neurosurgical drainage (stereotactic aspiration or craniotomy) + FESS for sinus source |
| Cavernous sinus thrombosis | IV antibiotics + anticoagulation (heparin — to prevent thrombus propagation) + source control |
| Step | Details |
|---|---|
| Antifungal therapy | IV amphotericin B (liposomal formulation preferred — less nephrotoxic) for Mucormycosis; IV voriconazole for Aspergillosis |
| Surgical debridement | Urgent, aggressive surgical debridement of all necrotic tissue — this is life-saving. Mucormycosis is angioinvasive → tissue necrosis is irreversible without physical removal |
| Correct underlying condition | Correct DKA, reduce immunosuppression if possible, treat neutropenia (G-CSF) |
| Mortality | High (40–80%) even with optimal treatment; outcome depends on early recognition and aggressive intervention |
6. Management of Specific CRS Subtypes
| Approach | Details |
|---|---|
| Avoid NSAIDs/aspirin | Triggers acute exacerbation via COX-1 inhibition → leukotriene overproduction |
| INCS | High-dose; consider steroid-eluting stents post-FESS |
| Leukotriene receptor antagonist | Montelukast — targets the specific pathophysiological mechanism |
| Aspirin desensitisation | After FESS, progressive aspirin challenge under supervision → once tolerated, maintenance aspirin 650 mg BD. This paradoxically down-regulates leukotriene production and reduces polyp recurrence. Only done in specialised centres. |
| Biologics | Dupilumab is first-line biologic for severe AERD refractory to above measures |
| Approach | Details |
|---|---|
| FESS | Complete removal of allergic mucin and polyps — essential for disease control |
| Post-operative INCS | Long-term; high-dose INCS irrigation (e.g., budesonide respules in saline irrigation) |
| Oral steroids | Short post-operative taper to prevent early recurrence |
| Antifungals | NOT routinely indicated (AFRS is an immune-mediated response to fungi, not invasive infection) |
| Immunotherapy | Allergen-specific immunotherapy may reduce recurrence in some patients |
| Approach | Details |
|---|---|
| FESS | Surgical removal of the fungal ball via endoscopic antrostomy. This is curative. |
| Antifungals | NOT required — the fungal ball is non-invasive in an immunocompetent host |
| Recurrence | Rare after complete removal |
| Category | First-Line | Second-Line | Surgical |
|---|---|---|---|
| Acute viral RS | Supportive: analgesia, saline irrigation, nasal decongestant [1][4][5] ± INCS [4][5] | — | Not applicable |
| ABRS (uncomplicated) | Amoxicillin × 5–10 d [1][4][5] + supportive | Amoxicillin-clavulanate or respiratory FQ | ENT referral if refractory |
| CRS without polyps | INCS + saline irrigation ± short Abx ± low-dose macrolide | Oral steroid taper, culture-directed Abx | FESS if refractory to max medical Tx |
| CRS with polyps | INCS + saline irrigation ± oral steroid taper | Biologics (dupilumab, omalizumab); montelukast | FESS + long-term INCS maintenance |
| Orbital complication | IV vancomycin + ceftriaxone/tazocin/unasyn [9] | Culture-directed adjustment | Surgical drainage if abscess [9] |
| Intracranial complication | IV ceftriaxone + metronidazole ± vancomycin | Culture-directed | Neurosurgical drainage + FESS |
| Invasive fungal | IV amphotericin B (Mucor) or voriconazole (Aspergillus) | — | Urgent surgical debridement |
High Yield Summary – Management of Sinusitis
-
Routine use of antibiotics does NOT prevent development of complications [4][5]. Most ARS is viral → supportive treatment only.
-
Supportive Tx: Analgesia + nasal saline irrigation + nasal decongestant (≤5–7 d) [1][4][5]. ± INCS if symptoms persist [4][5].
-
Antibiotics for ABRS only: First-line = Amoxicillin × 5–10 days [1][4][5]. Second-line = amoxicillin-clavulanate. FQ = last resort.
-
CRS management: Anti-inflammatory-focused. INCS is the cornerstone + saline irrigation. Surgery (FESS) if refractory to maximal medical therapy.
-
Biologics: Dupilumab (anti-IL-4Rα) is first-line biologic for severe CRSwNP refractory to conventional therapy.
-
Complications: Orbital — urgent CT, IV vancomycin + ceftriaxone, surgical drainage if abscess [9]. Intracranial — IV Abx + neurosurgery. Invasive fungal — IV amphotericin B + urgent debridement.
-
Nasal decongestant limit ≤5–7 days to avoid rhinitis medicamentosa.
-
FESS: Restore natural drainage at OMC; requires pre-op CT; post-op INCS + saline mandatory to prevent recurrence.
Active Recall - Management of Sinusitis
References
[1] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (Acute rhinosinusitis treatment, p16; External drainage, p20; Sinusitis definition, p14) [4] Senior notes: Ryan Ho Respiratory.pdf (Rhinosinusitis management, p54) [5] Senior notes: Adrian Lui Pediatrics Notes.pdf (Sinusitis management, p159) [9] Senior notes: Ryan Ho Opthalmology.pdf (Orbital cellulitis management, p38) [12] Senior notes: Ryan Ho Respiratory.pdf (URTI symptomatic treatment table, p49)
Complications of Sinusitis (Rhinosinusitis)
Complications of rhinosinusitis are uncommon but potentially life-threatening. They arise from spread beyond the paranasal sinuses [4][5] — either by direct extension through thin bony walls, retrograde thrombophlebitis via valveless veins, or haematogenous dissemination.
Understanding why complications occur requires appreciating the anatomy:
- The ethmoid sinuses are separated from the orbit by only the lamina papyracea ("paper-thin plate") — literally a paper-thin sheet of bone perforated by neurovascular foramina → orbital complications
- The frontal sinus posterior wall is thin → epidural abscess, meningitis; anterior wall → Pott's puffy tumour
- The sphenoid sinus is surrounded by the cavernous sinus, optic nerve, internal carotid artery, and pituitary → cavernous sinus thrombosis, optic nerve compromise
- Valveless diploic and emissary veins connect the sinus venous plexus to the dural venous sinuses → retrograde septic thrombophlebitis can propagate infection intracranially without needing to erode through bone
Complications from GC lecture slides (GC 215) [13]:
Orbital cellulitis, abscess Cavernous sinus thrombosis Intracranial infection: meningitis, encephalitis, abscess
Complications from CFB lecture slides [1]:
Complicated sinusitis: orbital cellulitis/abscess, meningitis/intracranial abscess
Complications are classically grouped into three anatomical categories [2][3][4][5]:
| Category | Specific Complications |
|---|---|
| Facial [4][5] | Facial cellulitis, osteomyelitis of sinus bones (Pott's puffy tumour) |
| Orbital [4][5] | Preseptal cellulitis, orbital cellulitis, subperiosteal abscess |
| Intracranial [4][5] | Meningitis, intracranial abscess (brain abscess, epidural abscess, subdural empyema), septic cavernous sinus thrombosis |
Additionally:
- Mucocoele / Mucopyocoele — a chronic complication of obstructed sinus
- Descending infection — pharyngeal/mediastinal spread (very rare)
3. Facial Complications
| Feature | Details |
|---|---|
| Definition | Soft tissue infection of the skin and subcutaneous tissue overlying the sinuses |
| Source sinus | Usually frontal or maxillary |
| Pathophysiology | Infection extends through the anterior bony wall of the sinus (or through valveless anterior facial veins draining the sinus mucosa) into the overlying soft tissues. In frontal sinusitis, the thin anterior table allows direct anterior spread. |
| Clinical features | Erythema, warmth, swelling, and tenderness over the affected sinus. Fever. Unlike orbital cellulitis, there is NO proptosis, NO ophthalmoplegia, NO visual impairment. |
| Management | IV antibiotics (amoxicillin-clavulanate or cephalosporin); treat underlying sinusitis; surgical drainage if abscess forms |
Osteomyelitis of sinus bone [2][3]:
- Presents with gradual onset of dull pain at involved site with or without movement [2][3]
- Local findings such as erythema, swelling, warmth and tenderness may be present [2][3]
- Systemic symptoms such as fever, chills and rigors may be present [2][3]
| Feature | Details |
|---|---|
| Definition | Subperiosteal abscess of the frontal bone with underlying frontal bone osteomyelitis. Despite the name, it is NOT a neoplasm — "tumour" in the original 18th-century sense simply means "swelling." |
| Eponym | Named after Sir Percival Pott (1714–1788), a London surgeon |
| Source | Frontal sinusitis — infection erodes through the anterior table of the frontal sinus |
| Pathophysiology | Frontal sinusitis → infection spreads through the anterior table of the frontal bone (direct erosion or via thrombophlebitis of diploic veins) → osteomyelitis of the frontal bone → pus collects between the outer table and the periosteum → doughy, non-tender to mildly tender frontal swelling |
| Clinical features | Doughy, fluctuant, non-tender frontal swelling ("puffy" appearance); overlying erythema; headache; fever; may coexist with intracranial complications (because infection can also spread posteriorly through the posterior table → epidural abscess) |
| Diagnosis | CT sinuses with contrast — shows frontal sinus opacification, anterior table erosion/destruction, subperiosteal fluid collection, ± posterior table involvement with intracranial extension |
| Management | Prolonged IV antibiotics (6+ weeks) + surgical drainage of the subperiosteal abscess + FESS for the frontal sinus. If posterior table involved, neurosurgical input required. |
Why is Pott's puffy tumour important? Because its presence implies frontal bone osteomyelitis, which means the infection has already breached bone. In ~60% of cases, there is concurrent intracranial extension (epidural abscess, subdural empyema). Therefore, any patient with a puffy frontal swelling following sinusitis must have a CT with contrast that includes the brain.
4. Orbital Complications
Orbital complications are the most common complication category of acute rhinosinusitis, especially in children. The most commonly implicated sinus is the ethmoid sinus — because only the paper-thin lamina papyracea separates the ethmoid air cells from the orbit.
The Chandler classification (1970) stages orbital complications in order of increasing severity:
| Stage | Name | Anatomical Location | Clinical Features | Management |
|---|---|---|---|---|
| I | Preseptal (periorbital) cellulitis | Anterior to the orbital septum (eyelid only) | Eyelid swelling and erythema. No proptosis, no ophthalmoplegia, no visual impairment [9]. May have mild fever. | Oral antibiotics (amoxicillin-clavulanate); close outpatient follow-up or admission if child/not improving. Can usually be managed medically. |
| II | Orbital cellulitis | Posterior to the orbital septum; diffuse inflammation of orbital fat | Eyelid swelling, deep eye pain, pain with eye movement, proptosis (may be subtle), ophthalmoplegia ± diplopia (most important feature), visual impairment ± RAPD, chemosis, fever [9]. Ophthalmic emergency [9]. | Admission, CT scan, urgent ophthalmologist assessment, IV antibiotic and drainage [1]. IV vancomycin + ceftriaxone/tazocin/unasyn [9]. |
| III | Subperiosteal abscess | Between the periorbita and the orbital wall (usually medial wall — lamina papyracea) | Proptosis with globe displacement (typically laterally and inferiorly from a medial collection). May have reduced extraocular motility. Fever, toxic appearance. Subperiosteal abscess (15–59% of orbital cellulitis cases): diagnosed by CT, requires urgent drainage [9]. | IV antibiotics + surgical drainage (endoscopic approach preferred — concurrent ethmoidectomy + abscess drainage via lamina papyracea). |
| IV | Orbital abscess | Within the orbital fat, posterior to septum | Severe proptosis, complete ophthalmoplegia, marked visual impairment, chemosis, severe pain, high fever. Orbital abscess (24%): diagnosed by CT [9]. | IV antibiotics + urgent surgical drainage (ophthalmology/ENT). High risk of visual loss. |
| V | Cavernous sinus thrombosis | Cavernous sinus | See below (Section 5.3). Septic cavernous sinus thrombosis [2][3][4][5]. | IV antibiotics + anticoagulation + source control |
Complicated sinusitis assessment (from CFB lecture slides) [1]:
- Present as orbital swelling/cellulitis
- Check colour vision — early sign of optic nerve compromise
- Check eye movement — ophthalmoplegia indicates post-septal disease
- Admission
- CT scan
- Urgent ophthalmologist assessment
- IV antibiotic and drainage
High Yield – CFB/GC Exam Point: Orbital Complication Assessment
When a patient with sinusitis presents with orbital swelling, you MUST assess:
- Colour vision — optic nerve function; desaturation of red (red appears washed out) is an early sign of optic neuropathy from compression or ischaemia
- Eye movement — restriction or pain with movement indicates post-septal disease (orbital cellulitis or abscess)
- Visual acuity — declining VA is an urgent indication for surgical drainage
- RAPD — relative afferent pupillary defect indicates optic nerve compromise
These are the features that distinguish the emergency (orbital cellulitis) from the non-emergency (preseptal cellulitis). [1]
Why do orbital complications develop from sinusitis?
-
Anatomical proximity: The ethmoid sinus shares the lamina papyracea ("papyrus-like plate") with the orbit. This bone is:
- Extremely thin (< 0.5 mm in places)
- Perforated by multiple neurovascular foramina (anterior and posterior ethmoidal arteries and nerves)
- Has natural dehiscences in up to 10% of the population
-
Routes of spread:
- Direct erosion: infection literally erodes through the thin bone into the orbit
- Valveless venous spread: the ethmoidal veins drain into the ophthalmic veins, which connect to the orbital venous plexus. These veins have no valves, meaning infected thrombophlebitis can propagate in any direction — anteriorly into the orbit or posteriorly into the cavernous sinus
- Pre-existing dehiscences: natural gaps in the lamina papyracea provide a path of least resistance
-
Why children are more affected: The lamina papyracea is thinner in children, the ethmoid sinuses are the first to develop and pneumatise, and the pediatric immune system may mount a more exuberant (but initially less effective) inflammatory response.
Visual loss may occur due to optic neuritis or ischaemia due to compressive CRAO (central retinal artery occlusion) or orbital venous thrombophlebitis [9].
Mechanism:
- Increasing orbital pressure from abscess/inflammation compresses the optic nerve or its blood supply
- Central retinal artery occlusion → retinal ischaemia → irreversible visual loss within hours
- Optic neuritis → inflammatory demyelination of the optic nerve from direct extension of infection
- Orbital venous congestion → secondary ischaemia
This is why visual acuity, colour vision, pupil assessment (RAPD), and fundoscopy are essential in any patient with orbital complications — and why declining vision is an indication for immediate surgical drainage, even if the patient is on IV antibiotics.
5. Intracranial Complications
Intracranial complications are the most dangerous and carry the highest mortality. They arise primarily from frontal, ethmoid, and sphenoid sinusitis.
| Feature | Details |
|---|---|
| Source sinus | Sphenoid, posterior ethmoid, frontal (posterior wall) |
| Pathophysiology | Direct extension: infection erodes through the posterior wall of the frontal sinus or the thin roof of the ethmoid (cribriform plate) or sphenoid into the meninges. Alternatively, retrograde thrombophlebitis via diploic veins carries infected material to the meninges. |
| Clinical features | Triad of headache, fever, and neck rigidity (meningism). Kernig's sign (pain/resistance on knee extension with hip flexed), Brudzinski's sign (involuntary hip/knee flexion on passive neck flexion). Photophobia, altered consciousness. |
| Microbiology | Reflects sinus flora: S. pneumoniae (most common), H. influenzae, anaerobes, S. aureus. Look for predisposing factors: sinusitis, endocarditis, otitis media, skull fracture, immunocompromised states [14]. |
| Diagnosis | Clinical suspicion → blood cultures → CT brain (rule out abscess/raised ICP before LP) → lumbar puncture: CSF shows turbid appearance, ↑PMNs (200–3000/mm³), ↑protein (0.5–2.0 g/L), ↓glucose (CSF:blood glucose < ½) [14]. |
| Management | Empirical IV antibiotics (ceftriaxone + vancomycin ± dexamethasone given before or with first antibiotic dose to reduce inflammatory damage). Source control: FESS to drain the sinus source. |
5.2 Brain Abscess and Epidural/Subdural Empyema
Brain abscess, epidural abscess [2][3]. Intracranial extension: CST/CVST, brain abscess, epidural/subdural empyema [9]. Look for severe headache, protracted vomiting, CN palsies and mental status changes [9].
| Feature | Details |
|---|---|
| Source sinus | Frontal sinus (most common source for sinogenic brain abscess — typically frontal lobe abscess) |
| Pathophysiology | Infection spreads from the frontal sinus through the posterior table into the epidural space, then through the dura into brain parenchyma. Alternatively, retrograde septic thrombophlebitis via valveless diploic veins seeds bacteria into the frontal lobe. Bacteria colonise → cerebritis (early, diffuse inflammation) → necrosis → capsule formation (mature abscess with central pus, rim of granulation tissue, surrounding oedema) [15]. |
| Microbiology | Sinus source: S. viridans, S. pneumoniae, Haemophilus spp, anaerobes [15]. Usually polymicrobial (mixed aerobe + anaerobe). |
| Clinical features | Initially non-specific symptoms → usually develop and progress over 2–3 weeks [15]. (1) Systemic: pyrexia, malaise → only 45–53% have fever → high index of suspicion [15]. (2) Raised ICP: severe ipsilateral headache (most common symptom, 69%), vomiting → ↓consciousness, papilloedema (late) [15]. (3) Focal neurological deficits (75%): hemiparesis, dysphasia, ataxia, nystagmus, seizures (30%) [15]. (4) Signs related to infective source (sinus tenderness, purulent discharge). |
| Diagnosis | Do NOT do lumbar puncture if focal signs present [15] — risk of tonsillar herniation. Contrast CT/MRI brain: cerebritis (early) → irregular non-enhancing hypodensity; abscess (late) → 3 layers: liquefactive debris (hypodense), capsule (rim enhancement), surrounding oedema (hypodense) [15]. ± midline shift/ventricular compression [15]. |
| Management | Empirical: IV ceftriaxone/cefotaxime + metronidazole [15]. Add vancomycin if haematogenous source suspected. Treat for at least 6 weeks with clinical-radiological monitoring [15]. Neurosurgery: large, single abscess/empyema → early drainage (stereotactic/US-guided aspiration or craniotomy) [15]. Small or multiple abscesses → may not require surgery, serial CT monitoring [15]. Prophylactic antiepileptics required [15]. Source control: FESS for sinus drainage. |
Key Point – Cerebral Abscess Abutting Ventricle
A cerebral abscess abutting the ventricle is a neurosurgical emergency → rupture into the ventricle causes fulminant ventriculitis → potential to result in permanent neurological damage [15]. This must be drained urgently. Always look at the relationship of the abscess to the ventricular system on imaging.
| Feature | Details |
|---|---|
| Definition | Collection of pus between the skull and the dura mater |
| Source | Frontal sinus (posterior table erosion) → most common |
| Pathophysiology | Frontal sinusitis erodes through the posterior table → pus accumulates in the potential epidural space. Unlike subdural empyema, the dura is a tough barrier and may initially contain the infection. |
| Clinical features | Persistent frontal headache (worse than expected for sinusitis alone), low-grade fever, may progress insidiously. Focal signs are less common early (the dura buffers against cortical compression). |
| Diagnosis | CT with contrast or MRI: lens-shaped (biconvex) enhancing collection between skull and dura |
| Management | Prolonged IV antibiotics + neurosurgical drainage (craniotomy or burr hole) + FESS for sinus source |
| Feature | Details |
|---|---|
| Definition | Collection of pus between the dura and the arachnoid membrane |
| Source | Frontal or ethmoid sinusitis; also otitis media/mastoiditis |
| Pathophysiology | Infection crosses the dura (via infected thrombus in bridging veins or direct erosion) and spreads in the subdural space. Unlike epidural abscess, the subdural space is a real space with no natural barriers to limit spread → empyema can extend rapidly over the cerebral convexity. Cortical vein thrombophlebitis → cortical infarction and seizures. |
| Clinical features | Rapidly progressive: severe headache, high fever, altered mental status, seizures (common — due to cortical irritation), hemiparesis, meningism. More dramatic and rapid than epidural abscess. |
| Diagnosis | CT with contrast or MRI: crescent-shaped (concave) enhancing collection over the cerebral convexity. MRI is superior (better sensitivity for thin collections). |
| Management | Neurosurgical emergency: urgent surgical drainage (craniotomy) + prolonged IV antibiotics + FESS for sinus source + antiepileptics |
Epidural vs Subdural — Why Does It Matter? Subdural empyema is far more dangerous than epidural abscess because (1) the subdural space has no barriers → rapid spread, (2) cortical veins traversing the subdural space thrombose → cortical infarction, and (3) seizures are common and early. Subdural empyema has a mortality of ~10–20% even with treatment, compared to ~5% for epidural abscess.
Septic cavernous sinus thrombosis [2][3][4][5][13]. Presents with cranial nerve palsies and headache [2][3].
| Feature | Details |
|---|---|
| Source sinus | Sphenoid, ethmoid, frontal. Also: dental infection, facial skin infection ("danger triangle of the face" — area bounded by the bridge of the nose and corners of the mouth, drained by the facial vein which communicates with the cavernous sinus via the ophthalmic veins). |
| Pathophysiology | Infection from the sinuses or face travels via the valveless venous system (emissary veins, ethmoidal veins → superior ophthalmic vein → cavernous sinus) carrying septic thrombus. The superior ophthalmic vein has no valves [9], allowing bidirectional flow and retrograde septic propagation. The thrombus within the cavernous sinus causes venous congestion and entraps the structures traversing through and along its walls. |
Structures within the cavernous sinus (and why CST causes specific signs):
| Structure | Location | Deficit When Affected |
|---|---|---|
| CN III (oculomotor) | Lateral wall | Ptosis, "down and out" eye, dilated pupil |
| CN IV (trochlear) | Lateral wall | Impaired depression in adducted eye (rarely isolated) |
| CN V₁ (ophthalmic division) | Lateral wall | Forehead/periorbital sensory loss |
| CN V₂ (maxillary division) | Lateral wall (inferior) | Cheek/upper lip sensory loss |
| CN VI (abducens) | Passes through the sinus (within the sinus, not in the wall) | Most vulnerable — lateral rectus palsy → cannot abduct eye → horizontal diplopia |
| Internal carotid artery | Passes through the sinus | Rarely thrombosed but can → carotid stenosis/stroke |
| Sympathetic plexus | Around the ICA | Horner's syndrome (miosis, ptosis, anhidrosis) |
| Feature | Details |
|---|---|
| Clinical features | (1) Bilateral orbital signs — because the two cavernous sinuses communicate via the intercavernous sinuses, so infection/thrombosis rapidly becomes bilateral. This is the key distinguishing feature from orbital cellulitis (which is unilateral). (2) Multiple cranial nerve palsies (III, IV, V₁, V₂, VI) → ophthalmoplegia, diplopia, facial numbness. (3) Proptosis, chemosis, periorbital oedema (venous congestion). (4) Visual impairment. (5) High fever, systemic toxicity, rapid deterioration. (6) Headache (often severe, retro-orbital or diffuse). |
| Diagnosis | CT with contrast: filling defect in cavernous sinus, enlarged superior ophthalmic vein, ± associated sinusitis. MRI/MR venography is more sensitive. |
| Management | IV antibiotics (broad-spectrum: vancomycin + ceftriaxone + metronidazole) + anticoagulation (heparin — controversial but widely used to prevent thrombus propagation) + source control (FESS for sinus drainage). |
| Mortality | Historically ~30–50%; modern treatment has reduced this to ~10–20%, but significant morbidity (residual CN palsies, visual loss, pituitary insufficiency) is common. |
Why Bilateral Orbital Signs = Cavernous Sinus Thrombosis
The two cavernous sinuses are connected by anterior and posterior intercavernous sinuses (circular sinus). This means that septic thrombosis in one cavernous sinus rapidly propagates to the contralateral side. If a patient with sinusitis develops BILATERAL proptosis, chemosis, and ophthalmoplegia — think CST immediately. This distinguishes it from orbital cellulitis, which is typically unilateral.
6. Other Complications
| Feature | Details |
|---|---|
| Definition | Mucocoele: a slowly expanding, mucus-filled cyst that forms when a sinus ostium becomes completely and chronically obstructed. Mucopyocoele: an infected mucocoele (pus-filled). |
| Source sinus | Most commonly frontal (60–65%) or ethmoid (25–30%) |
| Pathophysiology | Chronic ostial obstruction (post-surgical scarring, polyps, tumour, osteoma) → trapped mucus production continues → progressive expansion → pressure erosion of surrounding bone → can expand into the orbit, anterior cranial fossa, or subcutaneous tissue. This is a slow process (months to years). |
| Clinical features | Frontal: painless frontal swelling (globe displacement inferolaterally if eroding into orbit), proptosis, diplopia. Ethmoid: medial orbital swelling, proptosis, epiphora (lacrimal duct compression). Sphenoid: headache, visual loss (optic nerve compression), CN palsies. |
| Diagnosis | CT sinuses: well-circumscribed, homogeneously opacified, expanded sinus with smooth bony remodelling (not erosion/destruction — which would suggest malignancy). MRI: helps differentiate from tumour (mucocoele has characteristic signal depending on protein content). |
| Management | Surgical marsupialisation via FESS — open the mucocoele into the nasal cavity to restore drainage. Complete excision is not needed if adequate drainage is established. Mucopyocoele: add antibiotics. |
| Feature | Details |
|---|---|
| Pathophysiology | The Eustachian tube (pharyngotympanic tube) opens into the nasopharynx. Mucosal oedema and secretions from rhinosinusitis can obstruct the pharyngeal orifice of the Eustachian tube → negative middle ear pressure → serous effusion (secretory otitis media) → potential secondary bacterial infection (acute otitis media, AOM). Direct bacterial spread from the nasopharynx through the Eustachian tube can also cause AOM. |
| Clinical features | Ear fullness, conductive hearing loss, otalgia, tinnitus. AOM: severe ear pain, fever, bulging/erythematous tympanic membrane, otorrhoea if perforation occurs. |
| Relevance | Especially common in children (shorter, more horizontal Eustachian tube). Acute otitis media (especially in children) due to Eustachian tube dysfunction and bacterial translocation from upper respiratory tract [12]. |
| Condition | Mechanism |
|---|---|
| Asthma exacerbation | The "unified airway" concept: nasal and bronchial mucosa share a common respiratory epithelium. Inflammation in the upper airway triggers a nasobronchial reflex and systemic inflammatory mediators that increase bronchial hyperreactivity. Also, post-nasal drip directly irritates the lower airways. |
| Bronchiectasis exacerbation | Patients with bronchiectasis (especially from PCD, CF, or CVID) often have concurrent CRS. Sinus infection can serve as a reservoir for pathogens that seed the lower airways. |
| Feature | Details |
|---|---|
| Mechanism | In acute sinusitis: conductive anosmia (mucosal oedema physically blocks odorant molecules from reaching the olfactory cleft). In CRS: prolonged inflammation can cause sensorineural anosmia — direct damage to olfactory neurons in the olfactory epithelium (high on the nasal septum and superior turbinate near the cribriform plate). |
| Significance | Anosmia significantly impairs quality of life (inability to detect gas leaks, smoke, spoiled food; loss of taste perception). CRSwNP is one of the most common causes of anosmia. |
| Recovery | Conductive component often improves with medical/surgical treatment. Sensorineural component may be irreversible if prolonged. |
| Factor | Mechanism |
|---|---|
| Immunocompromise (DM, HIV, neutropenia, steroids, chemotherapy) | Impaired immune clearance allows infection to progress and invade beyond the sinuses. Particularly predisposes to invasive fungal sinusitis (Mucormycosis in DKA, Aspergillosis in neutropenia). |
| Delay in treatment | Untreated ABRS may progress, though routine use of antibiotics does NOT prevent development of complications [4][5] — complications can occur even with appropriate treatment in a small minority. |
| Paediatric age | Thinner lamina papyracea, more porous bone, developing immune system. Orbital complications are most common in children < 10 years. |
| Frontal sinusitis | The frontal sinus has the highest risk of intracranial complications due to thin posterior wall adjacent to the anterior cranial fossa. |
| Sphenoid sinusitis | Close proximity to cavernous sinus, optic nerve, internal carotid artery → high risk of devastating complications despite being a relatively uncommon site of isolated sinusitis. |
| Anatomical variants | Dehiscent lamina papyracea, Onodi cell (posterior ethmoid cell closely related to optic nerve) |
| Complication | Source Sinus | Key Clinical Feature | Key Investigation | Key Management |
|---|---|---|---|---|
| Facial cellulitis | Frontal/maxillary | Overlying skin erythema + swelling | Clinical + CT if concern for abscess | IV Abx |
| Pott's puffy tumour | Frontal | Doughy frontal swelling | CT with contrast (bone erosion) | IV Abx + surgical drainage |
| Preseptal cellulitis | Ethmoid | Eyelid oedema, NO ophthalmoplegia | Clinical ± CT | Oral Abx, close monitoring |
| Orbital cellulitis | Ethmoid | Proptosis, ophthalmoplegia, ↓vision [1][9] | CT scan [1] | IV Abx + drainage [1] |
| Subperiosteal abscess | Ethmoid | Globe displacement, proptosis | CT with contrast (rim-enhancing) | IV Abx + surgical drainage |
| Meningitis | Sphenoid/ethmoid/frontal | Headache, fever, meningism | LP (after CT), blood cultures | IV Abx + dexamethasone |
| Brain abscess | Frontal | Headache, FND, seizures | Contrast CT/MRI (rim-enhancing) | IV Abx 6 wk + drainage [15] |
| Epidural abscess | Frontal | Persistent headache | CT/MRI (biconvex collection) | IV Abx + neurosurgical drainage |
| Subdural empyema | Frontal/ethmoid | Rapid deterioration, seizures | MRI (crescent collection) | Emergency craniotomy + IV Abx |
| Cavernous sinus thrombosis | Sphenoid/ethmoid | Bilateral orbital signs, CN palsies [2][3] | CT/MRI/MR venography | IV Abx + heparin |
| Mucocoele | Frontal/ethmoid | Painless swelling, globe displacement | CT (expanded sinus, smooth remodelling) | Endoscopic marsupialisation |
High Yield Summary – Complications of Sinusitis
-
Complications are uncommon but due to spread beyond paranasal sinuses [4][5] — grouped into facial, orbital, and intracranial categories.
-
Most common complication category: Orbital — especially in children. Ethmoid sinusitis spreads via the lamina papyracea.
-
Preseptal vs orbital cellulitis: The critical distinction is ophthalmoplegia (post-septal). Check: colour vision, eye movement [1], visual acuity, RAPD.
-
Pott's puffy tumour: Frontal swelling = frontal bone osteomyelitis + subperiosteal abscess. ~60% have concurrent intracranial extension → always image the brain.
-
Cavernous sinus thrombosis: Bilateral orbital signs (because the two cavernous sinuses communicate). CN VI is most vulnerable (passes through the sinus). Cranial nerve palsies + headache [2][3].
-
Brain abscess from sinusitis: Frontal lobe abscess from frontal sinusitis. Headache is the most common symptom (69%). Only 45–53% have fever [15]. Treat for ≥6 weeks. Do NOT LP if focal signs [15].
-
Subdural empyema: More dangerous than epidural abscess (no barriers to spread, cortical vein thrombosis → seizures, infarction). Neurosurgical emergency.
-
Complicated sinusitis management (CFB): Admission → CT scan → urgent ophthalmologist assessment → IV antibiotic and drainage** [1].
Active Recall - Complications of Sinusitis
References
[1] Lecture slides: CFB WCS29_Common ENT conditions 2023.pdf (Complicated sinusitis, p18; Acute rhinosinusitis treatment, p16) [2] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (Complications of ARS, p138–140) [3] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (Complications of ARS, p114) [4] Senior notes: Ryan Ho Respiratory.pdf (Rhinosinusitis complications, p54) [5] Senior notes: Adrian Lui Pediatrics Notes.pdf (Sinusitis complications, p158–159) [9] Senior notes: Ryan Ho Opthalmology.pdf (Orbital cellulitis, p37–38) [12] Senior notes: Ryan Ho Respiratory.pdf (Coryza complications, p49) [13] Lecture slides: GC 215. Common nasal conditions and nasopharyngeal carcinoma.pdf (ABRS complications, p22) [14] Senior notes: Handbook of Internal Medicine 2024.pdf (CNS infections, p243) [15] Senior notes: Ryan Ho Neurology.pdf (Brain abscess, p150–151)
High Yield Summary
Definition: Rhinosinusitis = inflammation of the nasal cavity and paranasal sinuses. EPOS 2020 requires ≥2 symptoms (one must be nasal blockage/discharge) + objective evidence.
Classification: Acute ( < 12 wk), Chronic (≥12 wk), Recurrent acute (≥4 episodes/yr with resolution).
Etiology: Viral (>90% — rhinovirus MC), Bacterial (0.5–2% — S. pneumoniae, H. influenzae, M. catarrhalis), Fungal (immunocompromised).
Pathophysiology: Precipitating event → mucosal oedema → ostial obstruction → mucus stasis → ↓O₂ → bacterial overgrowth → more inflammation (vicious cycle). Nose blowing propels contaminated fluid into sinuses.
Key clinical criteria for bacterial RS: ≥3 of: (1) Double sickening, (2) Purulent discharge, (3) Severe localized pain, (4) Fever >38°C or ↑ESR/CRP.
Nasal discharge colour ≠ bacterial infection: Coloured discharge reflects PMN activity and is normal in viral colds.
Nasal polyps: Grey-white, mobile, painless (vs turbinate: pink, fixed, tender). Think CRSwNP, Samter's triad (asthma + polyps + aspirin sensitivity), cystic fibrosis, AFRS.
OMC: The bottleneck — any swelling here obstructs maxillary + anterior ethmoid + frontal sinuses simultaneously.
Red flags: Periorbital signs (orbital complication), altered consciousness/FND (intracranial complication), black eschar (mucormycosis), unilateral blood-stained discharge (NPC in HK).
High Yield Summary – Differential Diagnosis of Sinusitis
-
Most common DDx to rule out: Viral URTI (common cold) — self-limiting, < 10 d, not worsening. Bacterial RS is rare (0.5–2%) and diagnosed by duration ≥10 d, severe onset, or double sickening.
-
Most commonly misdiagnosed as sinusitis: Migraine — up to 80–90% of "sinus headaches" are actually migraine. Look for nausea, photophobia, and phonophobia (not features of sinusitis).
-
Must-not-miss in HK: NPC — unilateral nasal obstruction, blood-stained post-nasal drip, unilateral hearing loss/tinnitus, neck mass, cranial nerve palsies. Check EBV DNA.
-
Preseptal vs orbital cellulitis: Orbital cellulitis = ophthalmic emergency (proptosis, ophthalmoplegia, visual impairment). Most commonly from ethmoid sinusitis via lamina papyracea.
-
Syndromic patterns: Kartagener (sinusitis + bronchiectasis + situs inversus), CF (sinusitis + polyps + steatorrhoea), Samter's triad (CRSwNP + asthma + aspirin sensitivity), GPA (sinusitis + lung + kidney).
-
Unilateral nasal symptoms = red flag: Think foreign body (children), fungal ball, odontogenic sinusitis, malignancy (NPC, inverted papilloma, SCC).
High Yield Summary – Diagnosis of Sinusitis
-
Rhinosinusitis is a clinical diagnosis — no imaging needed for uncomplicated ARS.
-
EPOS 2020 criteria: ≥2 symptoms (1 nasal) + objective evidence (endoscopy or CT). Acute < 12 wk, Chronic ≥12 wk.
-
Three patterns for ABRS: (1) Persistent ≥10 d no improvement, (2) Severe onset ≥3–4 d, (3) Double sickening after 5–6 d.
-
Alternative bacterial scoring: ≥3 of — double sickening, purulent discharge, severe localised pain, fever > 38°C or ↑ESR/CRP.
-
Sinus X-ray: Poor sensitivity and specificity → NOT recommended. Poor ethmoid visualisation → high FN rates.
-
CT sinuses: Preferred imaging modality. Findings: air-fluid levels, mucosal oedema/thickening, air bubbles, opacification. With contrast for complications.
-
MRI: Best for soft tissue detail — complications, tumour characterisation, intracranial extension.
-
Sinus aspirate / endoscopic C/ST: NOT routine. Only for suspected serious complications, treatment failure, or immunocompromised.
-
CRS workup: Nasal endoscopy + CT sinuses (after maximal medical therapy) + allergy testing + eosinophils.
-
HK context: Unilateral bloody discharge → endoscopy + biopsy + EBV DNA to exclude NPC.
High Yield Summary – Management of Sinusitis
-
Routine use of antibiotics does NOT prevent development of complications [4][5]. Most ARS is viral → supportive treatment only.
-
Supportive Tx: Analgesia + nasal saline irrigation + nasal decongestant (≤5–7 d) [1][4][5]. ± INCS if symptoms persist [4][5].
-
Antibiotics for ABRS only: First-line = Amoxicillin × 5–10 days [1][4][5]. Second-line = amoxicillin-clavulanate. FQ = last resort.
-
CRS management: Anti-inflammatory-focused. INCS is the cornerstone + saline irrigation. Surgery (FESS) if refractory to maximal medical therapy.
-
Biologics: Dupilumab (anti-IL-4Rα) is first-line biologic for severe CRSwNP refractory to conventional therapy.
-
Complications: Orbital — urgent CT, IV vancomycin + ceftriaxone, surgical drainage if abscess [9]. Intracranial — IV Abx + neurosurgery. Invasive fungal — IV amphotericin B + urgent debridement.
-
Nasal decongestant limit ≤5–7 days to avoid rhinitis medicamentosa.
-
FESS: Restore natural drainage at OMC; requires pre-op CT; post-op INCS + saline mandatory to prevent recurrence.
High Yield Summary – Complications of Sinusitis
-
Complications are uncommon but due to spread beyond paranasal sinuses [4][5] — grouped into facial, orbital, and intracranial categories.
-
Most common complication category: Orbital — especially in children. Ethmoid sinusitis spreads via the lamina papyracea.
-
Preseptal vs orbital cellulitis: The critical distinction is ophthalmoplegia (post-septal). Check: colour vision, eye movement [1], visual acuity, RAPD.
-
Pott's puffy tumour: Frontal swelling = frontal bone osteomyelitis + subperiosteal abscess. ~60% have concurrent intracranial extension → always image the brain.
-
Cavernous sinus thrombosis: Bilateral orbital signs (because the two cavernous sinuses communicate). CN VI is most vulnerable (passes through the sinus). Cranial nerve palsies + headache [2][3].
-
Brain abscess from sinusitis: Frontal lobe abscess from frontal sinusitis. Headache is the most common symptom (69%). Only 45–53% have fever [15]. Treat for ≥6 weeks. Do NOT LP if focal signs [15].
-
Subdural empyema: More dangerous than epidural abscess (no barriers to spread, cortical vein thrombosis → seizures, infarction). Neurosurgical emergency.
-
Complicated sinusitis management (CFB): Admission → CT scan → urgent ophthalmologist assessment → IV antibiotic and drainage** [1].
Acute Coryza
Acute coryza is an acute viral infection of the upper respiratory tract, primarily affecting the nasal mucosa, commonly known as the common cold.
Rhinosinusitis
Inflammation of the nasal cavity and paranasal sinuses, typically presenting with nasal congestion, purulent discharge, facial pain, and reduced sense of smell.